,Open,High,Low,Close,Adjusted Close,Volume,Dividend Amount,Split Coefficient,Symbol,AssetType,Name,Description,CIK,Exchange,Currency,Country,Sector,Industry,Address,OfficialSite,FiscalYearEnd,LatestQuarter,MarketCapitalization,EBITDA,PERatio,PEGRatio,BookValue,DividendPerShare,DividendYield,EPS,RevenuePerShareTTM,ProfitMargin,OperatingMarginTTM,ReturnOnAssetsTTM,ReturnOnEquityTTM,RevenueTTM,GrossProfitTTM,DilutedEPSTTM,QuarterlyEarningsGrowthYOY,QuarterlyRevenueGrowthYOY,AnalystTargetPrice,AnalystRatingStrongBuy,AnalystRatingBuy,AnalystRatingHold,AnalystRatingSell,AnalystRatingStrongSell,TrailingPE,ForwardPE,PriceToSalesRatioTTM,PriceToBookRatio,EVToRevenue,EVToEBITDA,Beta,52WeekHigh,52WeekLow,50DayMovingAverage,200DayMovingAverage,SharesOutstanding,SharesFloat,PercentInsiders,PercentInstitutions,DividendDate,ExDividendDate
2014-01-31,45.800000,47.990000,41.850000,42.250000,42.250000,4392500,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-02-03,43.950000,43.950000,38.520000,39.000000,39.000000,498200,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-02-04,38.800000,40.250000,36.180000,36.260000,36.260000,352300,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-02-05,38.510000,38.510000,35.150000,36.080000,36.080000,296500,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-02-06,36.840000,38.680000,35.810000,37.240000,37.240000,188500,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-02-07,36.460000,38.290000,36.460000,37.650000,37.650000,62500,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-02-10,37.595000,39.920000,37.595000,38.450000,38.450000,90200,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-02-11,39.830000,40.589000,38.520000,40.130000,40.130000,83500,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-02-12,40.050000,46.000000,40.050000,44.780000,44.780000,291600,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-02-13,44.270000,44.950000,40.510000,43.960000,43.960000,169900,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-02-14,45.110000,45.180000,42.660000,44.000000,44.000000,37900,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-02-18,44.000000,44.995000,42.765800,43.570000,43.570000,45000,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-02-19,43.710000,44.890000,41.430000,43.850000,43.850000,104200,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-02-20,43.640000,51.870000,43.640000,51.350000,51.350000,182000,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-02-21,51.860000,62.480000,49.620000,59.100000,59.100000,227500,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-02-24,58.530000,59.810000,54.160000,58.010000,58.010000,165500,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-02-25,60.000000,63.855000,58.000000,59.000000,59.000000,244400,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-02-26,58.500000,60.520800,54.150000,56.070000,56.070000,93000,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-02-27,56.470000,57.649900,53.740000,54.000000,54.000000,95800,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-02-28,54.000000,57.250000,53.150000,55.760000,55.760000,110000,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-03-03,51.870000,59.310000,50.057000,55.530000,55.530000,131900,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-03-04,56.590000,59.989900,54.630000,58.220000,58.220000,98300,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-03-05,62.340000,62.340000,58.500000,58.750000,58.750000,103800,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-03-06,58.500000,59.290000,52.250000,54.380000,54.380000,163600,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-03-07,54.980000,58.960000,50.050000,56.625000,56.625000,147000,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-03-10,59.060000,62.609900,55.010000,61.970000,61.970000,217900,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-03-11,64.410000,64.890000,59.500000,62.380000,62.380000,231600,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-03-12,61.180000,66.500000,60.500000,66.180000,66.180000,77800,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-03-13,67.180000,69.773800,56.890000,60.480000,60.480000,275900,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-03-14,57.580000,61.680000,57.580000,60.000000,60.000000,84100,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-03-17,60.510000,61.240000,58.910000,60.060000,60.060000,83200,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-03-18,60.000000,61.240000,59.740000,60.440000,60.440000,81000,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-03-19,60.790000,64.720000,60.115000,62.750000,62.750000,104900,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-03-20,62.070000,62.850000,59.190000,60.350000,60.350000,91200,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-03-21,60.580000,61.250000,55.050000,55.050000,55.050000,426100,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-03-24,55.340000,57.961100,50.050000,51.410000,51.410000,241500,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-03-25,51.900000,54.200000,49.370000,50.400000,50.400000,189200,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-03-26,50.500000,51.442500,49.980000,50.690000,50.690000,119000,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-03-27,51.050000,53.250000,49.090000,49.790000,49.790000,112400,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-03-28,50.220000,51.240000,45.000000,45.690000,45.690000,212000,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-03-31,47.000000,48.960000,44.620000,48.890000,48.890000,978500,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-04-01,49.160000,51.910000,48.160000,51.320000,51.320000,160700,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-04-02,51.370000,53.360000,51.320000,53.030000,53.030000,125600,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-04-03,52.830000,52.830000,48.550000,51.740000,51.740000,195700,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-04-04,51.880000,52.225000,47.010000,50.670000,50.670000,122600,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-04-07,50.600000,52.200000,49.392500,51.170000,51.170000,90300,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-04-08,51.000000,53.120000,49.100000,52.800000,52.800000,244800,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-04-09,53.300000,60.000000,51.370000,58.800000,58.800000,168000,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-04-10,58.480000,58.840000,55.000000,57.940000,57.940000,148100,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-04-11,57.550000,60.000000,56.310000,58.990000,58.990000,378300,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-04-14,59.750000,59.750000,54.950000,55.060000,55.060000,265400,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-04-15,55.440000,55.520000,46.570000,49.890000,49.890000,638100,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-04-16,49.910000,49.910000,44.170000,45.220000,45.220000,251900,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-04-17,44.870000,44.870000,42.000000,42.560000,42.560000,410100,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-04-21,42.560000,43.000000,39.390000,41.040000,41.040000,277000,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-04-22,41.190000,43.490000,39.800000,41.430000,41.430000,354100,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-04-23,41.150000,41.500000,37.890000,38.240000,38.240000,151000,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-04-24,38.500000,38.560000,36.220000,37.830000,37.830000,165000,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-04-25,37.560000,37.560000,35.010000,35.250000,35.250000,184000,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-04-28,35.490000,37.860000,34.120000,36.840000,36.840000,143200,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-04-29,36.840000,38.790000,36.690000,38.520000,38.520000,149500,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-04-30,38.490000,38.980000,36.940000,38.780000,38.780000,313500,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-05-01,38.560000,39.880000,37.070000,38.850000,38.850000,123300,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-05-02,39.060000,39.210000,37.970000,38.560000,38.560000,72600,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-05-05,38.240000,39.330000,38.200000,38.540000,38.540000,110100,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-05-06,38.560000,38.560000,35.920000,36.240000,36.240000,103800,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-05-07,36.390000,37.980000,34.440000,35.140000,35.140000,166600,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-05-08,35.040000,37.370000,34.720000,34.930000,34.930000,119100,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-05-09,34.860000,36.670000,34.695000,36.550000,36.550000,68500,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-05-12,36.600000,37.826100,33.700000,34.040000,34.040000,248600,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-05-13,33.860000,34.220000,33.020000,33.440000,33.440000,147400,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-05-14,33.130000,35.490000,32.620000,35.260000,35.260000,192700,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-05-15,35.000000,37.320000,35.000000,36.360000,36.360000,148400,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-05-16,36.300000,37.370000,34.290000,34.480000,34.480000,95300,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-05-19,34.190000,36.020000,32.600400,33.800000,33.800000,109300,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-05-20,33.750000,34.290000,32.376000,33.360000,33.360000,182100,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-05-21,33.430000,34.359900,32.020000,33.740000,33.740000,119600,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-05-22,33.600000,34.715000,33.060000,34.500000,34.500000,92600,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-05-23,34.470000,35.250000,34.000000,35.210000,35.210000,51400,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-05-27,34.650000,37.130000,34.520000,37.100000,37.100000,102300,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-05-28,37.100000,37.250000,36.020000,36.160000,36.160000,67800,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-05-29,36.190000,38.010000,35.998000,37.920000,37.920000,45700,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-05-30,38.090000,38.359000,37.170000,37.560000,37.560000,105100,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-06-02,37.560000,37.990000,35.690000,37.420000,37.420000,69000,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-06-03,37.460000,37.460000,35.520000,35.620000,35.620000,111600,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-06-04,35.550000,36.000000,32.360000,33.550000,33.550000,155900,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-06-05,33.480000,34.360000,33.190000,34.280000,34.280000,142400,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-06-06,34.510000,35.990000,34.510000,35.510000,35.510000,62500,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-06-09,35.610000,37.910000,35.540000,37.850000,37.850000,63600,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-06-10,37.600000,37.990000,36.010000,36.780000,36.780000,67000,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-06-11,36.440000,36.720000,35.120000,35.910000,35.910000,119200,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-06-12,36.080000,37.220000,35.936000,36.980000,36.980000,87700,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-06-13,37.170000,37.850000,35.300000,36.910000,36.910000,123700,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-06-16,36.770000,40.980000,36.550000,40.810000,40.810000,142200,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-06-17,40.630000,42.950000,39.349000,42.580000,42.580000,149300,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-06-18,42.630000,50.930000,42.630000,48.670000,48.670000,435500,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-06-19,48.720000,49.700000,44.050000,44.600000,44.600000,178100,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-06-20,44.870000,47.961000,42.920000,47.490000,47.490000,268900,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-06-23,47.110000,48.760000,44.620000,44.770000,44.770000,125900,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-06-24,44.950000,49.520000,44.950000,45.440000,45.440000,185200,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-06-25,44.840000,47.300000,43.020000,45.480000,45.480000,199900,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-06-26,45.270000,46.260000,44.201000,44.690000,44.690000,117900,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-06-27,44.780000,45.390000,43.500000,44.750000,44.750000,144400,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-06-30,44.760000,46.000000,44.290000,44.890000,44.890000,70800,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-07-01,45.350000,48.480000,45.350000,47.900000,47.900000,142100,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-07-02,47.990000,49.740000,47.520000,49.570000,49.570000,75500,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-07-03,49.980000,50.910000,49.880000,50.310000,50.310000,40000,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-07-07,50.350000,50.350000,46.740000,46.860000,46.860000,148800,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-07-08,45.980000,45.980000,40.570000,41.400000,41.400000,511600,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-07-09,40.500000,40.990000,37.770000,40.000000,40.000000,1887600,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-07-10,38.990000,41.170000,37.990000,40.370000,40.370000,453700,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-07-11,40.370000,43.770000,39.770100,42.970000,42.970000,270700,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-07-14,43.100000,44.480000,41.630000,43.850000,43.850000,280900,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-07-15,43.620000,43.830000,41.020000,41.990000,41.990000,332800,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-07-16,43.250000,44.590000,41.610000,42.930000,42.930000,278500,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-07-17,42.620000,44.340000,39.210000,39.890000,39.890000,365600,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-07-18,39.740000,43.440000,39.340000,43.000000,43.000000,674600,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-07-21,43.290000,43.730000,42.380000,43.240000,43.240000,248400,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-07-22,43.370000,43.730000,42.580000,42.970000,42.970000,141700,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-07-23,43.400000,44.300000,42.800000,43.050000,43.050000,213300,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-07-24,43.410000,43.870000,42.730000,43.270000,43.270000,109000,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-07-25,42.870000,43.650000,42.550000,43.110000,43.110000,164800,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-07-28,43.020000,43.090000,40.130000,40.670000,40.670000,133800,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-07-29,40.600000,41.980000,40.210000,41.520000,41.520000,110700,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-07-30,41.780000,44.050000,39.800000,43.760000,43.760000,395700,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-07-31,43.380000,44.000000,42.330000,43.700000,43.700000,195900,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-08-01,43.600000,43.970000,41.110000,42.740000,42.740000,1289900,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-08-04,43.170000,46.080000,42.160000,45.650000,45.650000,477500,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-08-05,44.970000,48.990000,44.260000,48.500000,48.500000,402200,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-08-06,49.240000,50.348000,47.430100,50.000000,50.000000,727200,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-08-07,49.780000,49.980000,48.500000,49.150000,49.150000,936400,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-08-08,49.170000,50.000000,47.870000,49.490000,49.490000,669000,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-08-11,49.840000,50.000000,48.270000,49.150000,49.150000,1373300,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-08-12,49.210000,51.790000,48.735000,50.440000,50.440000,350400,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-08-13,50.540000,54.480000,50.490000,53.450000,53.450000,343100,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-08-14,53.450000,54.470000,52.090000,53.900000,53.900000,131500,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-08-15,54.140000,54.980000,52.460000,54.010000,54.010000,143200,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-08-18,54.660000,56.240000,53.570000,56.010000,56.010000,202800,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-08-19,55.480000,57.240000,54.310000,55.880000,55.880000,608800,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-08-20,55.460000,56.520000,54.920000,56.030000,56.030000,811100,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-08-21,56.010000,56.150000,52.310000,53.150000,53.150000,954000,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-08-22,52.160000,53.244800,51.820000,52.320000,52.320000,737400,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-08-25,53.120000,55.220000,52.050000,53.330000,53.330000,972800,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-08-26,53.260000,54.290000,52.320000,52.730000,52.730000,1308900,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-08-27,52.630000,53.810000,52.430000,52.930000,52.930000,184700,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-08-28,52.400000,54.135000,52.400000,53.870000,53.870000,358800,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-08-29,54.400000,54.690000,52.600000,53.360000,53.360000,473800,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-09-02,52.820000,53.760000,51.960100,53.410000,53.410000,191700,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-09-03,54.510000,59.140000,53.460000,55.700000,55.700000,561500,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-09-04,56.340000,56.610000,54.200500,56.060000,56.060000,921300,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-09-05,55.840000,55.930000,53.470000,54.260000,54.260000,1016600,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-09-08,54.140000,55.760000,53.990000,54.740000,54.740000,189600,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-09-09,54.190000,57.000000,53.820000,55.070000,55.070000,359800,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-09-10,54.820000,58.425000,54.248000,58.060000,58.060000,300300,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-09-11,57.880000,57.960000,56.340000,57.670000,57.670000,263200,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-09-12,57.450000,58.990000,56.540000,57.720000,57.720000,473900,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-09-15,57.560000,57.810000,55.540100,56.625000,56.625000,484600,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-09-16,56.230000,56.740000,55.560000,56.340000,56.340000,675900,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-09-17,56.430000,57.350000,55.430000,55.960000,55.960000,281300,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-09-18,56.390000,56.390000,55.350000,55.690000,55.690000,196900,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-09-19,55.860000,56.070000,54.170000,54.720000,54.720000,1549800,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-09-22,54.290000,54.660000,51.730000,54.190000,54.190000,759000,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-09-23,54.680000,56.270000,54.390000,55.470000,55.470000,317000,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-09-24,55.710000,57.240000,55.500000,56.660000,56.660000,309745,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-09-25,56.610000,56.760000,54.620000,56.100000,56.100000,402124,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-09-26,56.480000,57.420000,55.630000,57.200000,57.200000,238751,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-09-29,56.410000,60.040000,56.390000,59.770000,59.770000,464134,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-09-30,59.920000,59.920000,56.520000,56.600000,56.600000,283269,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-10-01,56.870000,57.740000,54.130000,54.930000,54.930000,839899,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-10-02,54.760000,56.560000,54.390000,56.060000,56.060000,303275,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-10-03,56.780000,57.420000,55.140000,57.280000,57.280000,94818,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-10-06,57.510000,58.330000,56.750000,58.020000,58.020000,408815,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-10-07,57.550000,57.735000,53.664000,53.730000,53.730000,296868,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-10-08,53.260000,53.905000,50.820000,53.300000,53.300000,294877,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-10-09,53.320000,54.030000,51.130000,51.320000,51.320000,274697,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-10-10,51.270000,52.470000,49.670000,49.900000,49.900000,181830,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-10-13,50.030000,50.520000,46.640000,47.220000,47.220000,224736,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-10-14,47.810000,48.560000,43.980000,44.510000,44.510000,342662,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-10-15,43.630000,48.510000,42.190000,48.280000,48.280000,435370,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-10-16,48.350000,50.160000,47.480000,48.520000,48.520000,186432,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-10-17,49.500000,50.420000,46.630000,46.860000,46.860000,303189,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-10-20,46.210000,46.890000,44.500500,45.920000,45.920000,214455,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-10-21,46.230000,48.000000,46.220000,47.200000,47.200000,219788,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-10-22,47.070000,47.820000,45.000000,45.440000,45.440000,221399,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-10-23,46.340000,50.190000,45.090000,49.730000,49.730000,150878,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-10-24,49.550000,51.350000,49.050000,50.220000,50.220000,99867,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-10-27,49.910000,50.880000,48.780000,49.290000,49.290000,84088,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-10-28,49.600000,50.680000,48.700000,50.000000,50.000000,173238,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-10-29,49.940000,50.665000,49.440000,49.900000,49.900000,139619,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-10-30,49.590000,50.460000,48.180000,49.330000,49.330000,153499,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-10-31,50.420000,51.640000,46.230000,47.010000,47.010000,264480,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-11-03,46.950000,47.420000,44.670000,44.800000,44.800000,213170,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-11-04,44.530000,44.980000,44.000000,44.580000,44.580000,149786,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-11-05,45.100000,45.170000,43.447500,44.590000,44.590000,192506,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-11-06,44.520000,45.180000,43.190000,44.860000,44.860000,245034,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-11-07,44.770000,45.700000,44.140000,44.710000,44.710000,244115,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-11-10,45.110000,46.450000,40.580000,41.160000,41.160000,388815,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-11-11,40.930000,42.930000,40.620000,42.840000,42.840000,243844,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-11-12,41.850000,44.610000,41.370000,44.260000,44.260000,160282,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-11-13,44.300000,44.300000,43.290000,43.630000,43.630000,235615,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-11-14,43.780000,43.960000,41.200000,41.910000,41.910000,243455,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-11-17,41.570000,42.330000,41.040000,41.670000,41.670000,160991,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-11-18,42.170000,44.740000,41.800000,44.560000,44.560000,178979,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-11-19,44.500000,44.910000,44.000000,44.500000,44.500000,159946,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-11-20,44.070000,44.930000,43.320000,44.670000,44.670000,113350,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-11-21,45.510000,45.510000,43.850000,44.090000,44.090000,124320,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-11-24,44.720000,45.560000,43.900000,44.910000,44.910000,229896,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-11-25,44.890000,45.720000,42.770000,43.330000,43.330000,279928,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-11-26,43.260000,45.360000,43.260000,45.040000,45.040000,171530,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-11-28,44.950000,45.489900,43.370000,43.590000,43.590000,95524,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-12-01,43.260000,43.580000,41.070000,41.380000,41.380000,204155,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-12-02,42.380000,43.360000,41.580000,42.550000,42.550000,127147,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-12-03,42.770000,43.609900,41.530000,43.070000,43.070000,125757,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-12-04,42.600000,43.540000,40.140000,40.350000,40.350000,288714,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-12-05,40.320000,42.930000,39.500000,40.350000,40.350000,456292,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-12-08,40.180000,42.445000,40.000000,40.520000,40.520000,291243,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-12-09,39.970000,42.195000,39.970000,40.900000,40.900000,324273,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-12-10,40.220000,42.150000,39.500000,39.550000,39.550000,293681,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-12-11,39.600000,40.000000,38.010000,39.090000,39.090000,254763,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-12-12,38.520000,41.580000,38.510000,41.480000,41.480000,241626,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-12-15,42.150000,42.250000,39.130000,39.760000,39.760000,277997,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-12-16,39.470000,41.550000,39.460000,40.650000,40.650000,258013,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-12-17,40.690000,44.660000,40.690000,44.270000,44.270000,248663,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-12-18,44.910000,47.360000,44.360000,46.650000,46.650000,410665,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-12-19,47.600000,48.790000,45.260000,48.380000,48.380000,1488019,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-12-22,48.670000,49.740000,47.560000,49.270000,49.270000,244415,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-12-23,49.170000,49.170000,45.170000,45.730000,45.730000,224513,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-12-24,45.800000,46.260000,43.674500,45.170000,45.170000,182222,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-12-26,45.460000,45.460000,43.360000,44.060000,44.060000,250284,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-12-29,44.040000,44.400000,43.290000,43.600000,43.600000,281273,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-12-30,43.810000,44.460000,43.350000,44.040000,44.040000,156138,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2014-12-31,44.110000,44.400000,43.130000,43.880000,43.880000,170394,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-01-02,44.420000,46.900000,44.270000,46.400000,46.400000,148253,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-01-05,46.210000,47.720000,45.370000,47.500000,47.500000,169721,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-01-06,47.850000,49.790000,46.410000,47.100000,47.100000,251098,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-01-07,47.520000,49.730000,47.070000,48.650000,48.650000,165354,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-01-08,50.550000,53.860000,50.020000,51.900000,51.900000,355966,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-01-09,52.500000,54.890000,50.620000,54.060000,54.060000,560684,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-01-12,54.900000,56.190000,52.350000,55.810000,55.810000,581112,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-01-13,56.680000,56.680000,51.770000,53.320000,53.320000,498102,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-01-14,51.510000,54.875000,51.500000,53.990000,53.990000,173082,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-01-15,53.080000,53.940000,50.339400,50.770000,50.770000,169982,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-01-16,50.950000,54.330000,50.950000,53.260000,53.260000,238740,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-01-20,54.020000,54.020000,50.710100,52.920000,52.920000,143328,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-01-21,51.660000,51.660000,49.410000,50.290000,50.290000,617136,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-01-22,50.440000,52.580000,48.961000,51.870000,51.870000,607708,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-01-23,51.560000,52.930000,51.150000,52.210000,52.210000,238875,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-01-26,51.100000,58.980000,50.830000,58.210000,58.210000,383133,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-01-27,57.420000,58.804200,56.501000,57.510000,57.510000,155836,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-01-28,57.730000,57.850000,54.760000,56.110000,56.110000,157360,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-01-29,56.030000,58.955000,55.160000,58.000000,58.000000,152948,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-01-30,57.550000,59.000000,57.250000,58.100000,58.100000,243825,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-02-02,58.180000,58.770000,55.640000,56.740000,56.740000,202055,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-02-03,57.330000,57.970000,55.550000,57.580000,57.580000,179237,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-02-04,55.830000,56.189000,49.080000,55.230000,55.230000,609058,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-02-05,54.440000,55.050000,52.800000,54.990000,54.990000,1570075,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-02-06,55.170000,55.499000,53.210000,53.400000,53.400000,691385,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-02-09,53.400000,54.090000,52.250000,52.510000,52.510000,337865,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-02-10,53.200000,54.450000,52.230000,53.650000,53.650000,265700,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-02-11,54.370000,54.990000,52.730000,53.010000,53.010000,333780,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-02-12,53.430000,54.390000,52.134500,53.980000,53.980000,202684,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-02-13,54.250000,54.740000,53.550000,54.100000,54.100000,208564,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-02-17,54.200000,55.000000,53.420000,54.480000,54.480000,134746,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-02-18,54.100000,55.700000,53.610000,55.450000,55.450000,342994,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-02-19,55.460000,55.540000,54.670000,55.380000,55.380000,226942,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-02-20,55.420000,56.090000,54.970000,55.570000,55.570000,199040,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-02-23,55.580000,56.540000,55.000000,55.690000,55.690000,172310,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-02-24,55.710000,56.380000,52.640000,53.590000,53.590000,198244,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-02-25,53.590000,55.980000,52.690000,55.750000,55.750000,269702,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-02-26,55.840000,56.579900,53.830000,56.420000,56.420000,153047,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-02-27,56.110000,56.460000,53.580000,54.270000,54.270000,273542,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-03-02,54.460000,58.270000,54.460000,57.390000,57.390000,295911,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-03-03,57.040000,57.040000,54.900000,55.730000,55.730000,167321,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-03-04,55.130000,57.490000,54.080000,56.770000,56.770000,120103,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-03-05,57.760000,60.000000,56.480000,59.220000,59.220000,304073,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-03-06,59.280000,61.690000,58.510000,59.250000,59.250000,594613,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-03-09,59.730000,60.000000,55.390000,57.190000,57.190000,252442,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-03-10,56.410000,58.170000,55.450000,56.620000,56.620000,185597,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-03-11,56.300000,58.000000,55.910000,56.580000,56.580000,199664,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-03-12,56.890000,57.450000,55.540000,56.830000,56.830000,285850,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-03-13,56.790000,58.180000,55.030500,57.230000,57.230000,253354,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-03-16,58.300000,59.310000,57.800000,58.940000,58.940000,399429,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-03-17,58.740000,62.680000,58.710000,62.210000,62.210000,499593,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-03-18,61.450000,62.710000,59.050000,60.920000,60.920000,433216,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-03-19,60.430000,64.990000,60.240000,62.890000,62.890000,466035,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-03-20,63.450000,64.190000,60.489700,62.060000,62.060000,585405,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-03-23,61.530000,61.530000,56.880000,59.960000,59.960000,296014,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-03-24,60.460000,61.250000,58.060000,58.370000,58.370000,233211,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-03-25,64.450000,64.450000,55.864000,56.630000,56.630000,639925,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-03-26,56.210000,56.480000,52.031000,54.170000,54.170000,498652,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-03-27,54.030000,57.360000,53.730000,56.560000,56.560000,310032,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-03-30,56.680000,61.050000,56.160000,60.950000,60.950000,338523,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-03-31,61.870000,65.350000,60.330000,62.090000,62.090000,929132,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-04-01,63.000000,63.660000,59.230000,61.390000,61.390000,430415,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-04-02,61.630000,62.380000,60.250000,62.200000,62.200000,303147,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-04-06,61.610000,62.350000,57.820000,58.800000,58.800000,272728,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-04-07,58.740000,60.730000,58.370000,58.480000,58.480000,310544,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-04-08,58.020000,60.990000,58.020000,59.950000,59.950000,189314,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-04-09,60.140000,60.760000,57.740000,60.070000,60.070000,148901,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-04-10,60.330000,62.290000,59.610000,62.140000,62.140000,165066,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-04-13,62.000000,63.750000,62.000000,62.900000,62.900000,289417,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-04-14,63.170000,64.680000,62.340000,63.050000,63.050000,180698,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-04-15,63.440000,64.490000,62.090000,64.270000,64.270000,195110,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-04-16,64.640000,65.420000,64.140000,65.000000,65.000000,315731,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-04-17,64.700000,65.070000,62.000000,62.950000,62.950000,276772,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-04-20,63.350000,63.350000,60.500000,62.590000,62.590000,96560,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-04-21,63.280000,64.360000,61.030000,64.220000,64.220000,254711,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-04-22,64.000000,69.670000,63.880000,66.960000,66.960000,418503,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-04-23,67.370000,69.860000,67.020000,68.900000,68.900000,290495,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-04-24,68.900000,70.470000,68.300000,69.650000,69.650000,191130,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-04-27,69.860000,70.690000,63.560000,63.890000,63.890000,465336,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-04-28,63.990000,65.430000,58.000000,59.500000,59.500000,499091,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-04-29,58.990000,61.080000,58.440000,59.520000,59.520000,310310,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-04-30,59.110000,60.125000,56.110000,56.430000,56.430000,314112,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-05-01,57.260000,60.910000,56.950000,59.820000,59.820000,380031,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-05-04,60.220000,63.390000,60.120100,61.670000,61.670000,559821,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-05-05,61.060000,63.540000,60.010000,62.630000,62.630000,455027,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-05-06,66.650000,70.250000,63.440000,64.500000,64.500000,1136692,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-05-07,62.350000,64.830000,61.630000,61.900000,61.900000,740882,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-05-08,63.200000,64.680000,61.700000,63.000000,63.000000,382330,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-05-11,63.570000,67.690000,62.892000,67.220000,67.220000,279727,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-05-12,67.300000,75.470000,63.490000,72.270000,72.270000,883579,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-05-13,72.040000,74.000000,70.880100,73.760000,73.760000,544572,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-05-14,73.700000,76.160000,70.495000,75.500000,75.500000,426826,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-05-15,75.500000,79.990000,74.370000,79.340000,79.340000,481109,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-05-18,79.670000,82.770000,78.420000,81.410000,81.410000,419916,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-05-19,81.790000,85.930000,81.140000,83.340000,83.340000,588789,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-05-20,82.900000,84.900000,80.250000,84.520000,84.520000,319022,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-05-21,84.560000,85.730000,83.810000,84.890000,84.890000,176211,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-05-22,84.990000,85.790000,82.550000,83.130000,83.130000,364273,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-05-26,82.830000,83.250000,81.230000,82.640000,82.640000,410098,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-05-27,83.230000,88.230000,83.200000,86.740000,86.740000,581868,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-05-28,86.100000,88.270000,84.280000,88.060000,88.060000,300795,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-05-29,88.090000,89.690000,86.650000,87.000000,87.000000,346808,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-06-01,87.430000,87.890000,84.530000,86.650000,86.650000,300340,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-06-02,89.000000,93.480000,88.200000,92.560000,92.560000,628472,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-06-03,91.650000,95.640000,90.760000,91.620000,91.620000,448327,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-06-04,91.030000,93.000000,86.130000,87.030000,87.030000,480946,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-06-05,87.420000,91.000000,87.420000,89.240000,89.240000,398770,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-06-08,90.230000,90.999900,87.020000,88.770000,88.770000,234378,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-06-09,88.230000,90.190000,86.530000,89.050000,89.050000,210494,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-06-10,88.190000,90.970000,86.790000,89.620000,89.620000,282426,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-06-11,90.280000,90.950000,85.610000,87.720000,87.720000,332917,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-06-12,87.450000,88.500000,85.750000,88.270000,88.270000,211313,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-06-15,87.310000,89.670000,85.940000,88.660000,88.660000,306916,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-06-16,88.270000,92.430000,87.940000,92.110000,92.110000,351561,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-06-17,92.620000,97.000000,92.120000,95.000000,95.000000,352249,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-06-18,95.670000,100.720000,95.670000,97.850000,97.850000,494752,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-06-19,97.880000,100.940000,96.230000,100.590000,100.590000,610188,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-06-22,100.990000,104.299900,99.281800,102.970000,102.970000,417684,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-06-23,102.820000,104.250000,99.215000,103.710000,103.710000,469297,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-06-24,103.730000,104.050000,99.789000,100.300000,100.300000,381788,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-06-25,100.410000,101.405000,96.020000,99.830000,99.830000,434408,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-06-26,100.000000,103.460000,100.000000,103.160000,103.160000,4144479,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-06-29,102.260000,105.970000,98.220000,98.440000,98.440000,447215,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-06-30,99.840000,102.530000,98.190000,102.390000,102.390000,306287,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-07-01,103.610000,105.393000,102.060000,103.860000,103.860000,274470,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-07-02,104.020000,104.770000,100.160000,102.710000,102.710000,231468,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-07-06,102.480000,104.450000,100.050000,102.700000,102.700000,274757,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-07-07,103.220000,105.560000,100.420000,104.380000,104.380000,326166,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-07-08,102.950000,104.400000,98.680000,99.020000,99.020000,340656,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-07-09,103.440000,113.420000,103.440000,112.650000,112.650000,754750,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-07-10,114.450000,118.130000,111.640000,116.940000,116.940000,690188,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-07-13,118.090000,119.850000,117.020100,118.970000,118.970000,516293,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-07-14,119.310000,127.550000,119.010100,126.770000,126.770000,498501,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-07-15,123.500000,133.960000,122.590000,126.200000,126.200000,686857,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-07-16,124.490000,126.500000,121.910000,124.870000,124.870000,2269906,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-07-17,125.060000,133.280000,123.620000,132.800000,132.800000,756510,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-07-20,134.780000,137.050000,130.970000,134.090000,134.090000,662748,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-07-21,133.000000,136.736000,125.612000,128.200000,128.200000,499980,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-07-22,127.000000,133.320000,127.000000,131.910000,131.910000,417416,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-07-23,131.850000,134.670200,131.010000,133.380000,133.380000,473573,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-07-24,132.060000,135.430000,130.040000,131.360000,131.360000,658504,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-07-27,125.760000,126.540000,116.600000,117.060000,117.060000,756010,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-07-28,118.640000,122.310000,115.070000,120.600000,120.600000,426735,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-07-29,120.040000,121.640000,110.280000,116.440000,116.440000,490261,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-07-30,116.370000,116.540000,110.910000,115.820000,115.820000,484559,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-07-31,115.090000,121.380000,115.090000,120.930000,120.930000,709171,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-08-03,120.440000,122.788000,116.200000,117.760000,117.760000,278012,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-08-04,118.290000,119.170000,115.270000,116.450000,116.450000,343905,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-08-05,118.180000,122.700000,116.570000,120.270000,120.270000,288475,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-08-06,120.890000,121.818300,110.680000,112.470000,112.470000,487816,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-08-07,112.100000,112.470000,105.690000,109.640000,109.640000,350391,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-08-10,111.040000,116.840000,110.760000,113.890000,113.890000,340950,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-08-11,112.620000,115.480000,110.330000,111.900000,111.900000,262286,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-08-12,109.700000,116.800000,106.020000,114.920000,114.920000,418894,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-08-13,115.920000,119.440000,111.890000,112.300000,112.300000,304726,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-08-14,110.180000,113.740000,106.235000,110.510000,110.510000,474676,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-08-17,109.850000,114.980000,109.330000,114.670000,114.670000,275830,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-08-18,114.270000,117.010000,111.140000,111.610000,111.610000,476926,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-08-19,110.660000,119.500000,109.940000,116.990000,116.990000,741443,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-08-20,115.770000,116.400000,106.830000,108.110000,108.110000,827728,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-08-21,103.400000,108.580000,101.930000,102.870000,102.870000,925202,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-08-24,97.980000,103.150000,91.805000,93.510000,93.510000,771797,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-08-25,97.530000,102.710000,94.010000,99.290000,99.290000,657332,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-08-26,101.890000,107.840000,97.150000,107.400000,107.400000,697186,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-08-27,109.780000,113.790000,104.310000,108.100000,108.100000,600125,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-08-28,107.030000,114.829700,106.240000,113.430000,113.430000,451442,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-08-31,112.500000,115.064400,110.560000,111.620000,111.620000,365307,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-09-01,110.000000,113.920000,108.140000,111.080000,111.080000,709479,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-09-02,112.920000,121.760000,109.850100,121.690000,121.690000,494840,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-09-03,115.510000,119.430000,114.000100,116.250000,116.250000,522989,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-09-04,114.860000,119.000000,113.760000,116.290000,116.290000,340418,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-09-08,118.800000,125.170000,116.830000,124.830000,124.830000,367844,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-09-09,126.000000,127.580000,120.000000,121.030000,121.030000,276939,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-09-10,120.740000,122.990000,119.070000,120.580000,120.580000,401152,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-09-11,119.570000,121.984900,119.270000,121.710000,121.710000,302498,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-09-14,122.320000,124.160000,119.250000,122.830000,122.830000,262238,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-09-15,122.880000,125.890000,121.640000,123.750000,123.750000,286997,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-09-16,124.220000,127.580000,121.150000,124.710000,124.710000,396756,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-09-17,124.450000,133.400000,123.620000,131.470000,131.470000,346876,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-09-18,129.110000,131.310000,128.470000,129.910000,129.910000,835187,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-09-21,130.050000,130.830000,110.000000,111.800000,111.800000,807506,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-09-22,109.790000,111.075000,103.010000,107.630000,107.630000,735363,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-09-23,107.650000,111.000000,105.010000,106.410000,106.410000,370011,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-09-24,105.430000,106.290000,97.610000,101.680000,101.680000,490867,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-09-25,103.610000,103.610000,92.130000,94.110000,94.110000,607465,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-09-28,93.020000,97.010000,84.720000,87.890000,87.890000,822575,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-09-29,88.270000,94.870000,83.400000,86.610000,86.610000,551053,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-09-30,88.390000,96.790000,86.445000,96.310000,96.310000,634743,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-10-01,95.320000,99.440000,90.240000,98.980000,98.980000,537700,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-10-02,96.660000,108.000000,94.220000,104.690000,104.690000,656038,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-10-05,106.510000,107.640000,98.140000,100.000000,100.000000,407966,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-10-06,99.470000,101.720000,89.000000,94.120000,94.120000,564687,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-10-07,94.990000,95.900000,90.320000,95.270000,95.270000,375954,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-10-08,94.560000,99.930000,81.810000,87.870000,87.870000,704141,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-10-09,88.050000,93.270000,85.780000,90.700000,90.700000,472810,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-10-12,91.560000,93.000000,88.815000,89.890000,89.890000,333497,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-10-13,89.840000,89.850000,82.110000,82.490000,82.490000,703207,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-10-14,83.300000,86.590000,79.340000,81.130000,81.130000,532412,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-10-15,81.090000,86.156000,80.590000,84.850000,84.850000,844489,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-10-16,85.270000,89.380000,84.490000,86.810000,86.810000,456715,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-10-19,87.010000,91.490000,83.815000,88.940000,88.940000,540376,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-10-20,88.540000,89.090000,85.190000,85.740000,85.740000,486711,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-10-21,86.580000,88.570000,81.540000,87.020000,87.020000,323399,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-10-22,87.310000,93.680000,84.760000,90.720000,90.720000,592956,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-10-23,92.620000,101.540000,92.290000,96.950000,96.950000,576566,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-10-26,96.280000,100.730000,93.330000,97.280000,97.280000,356951,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-10-27,97.030000,102.390000,96.250000,101.250000,101.250000,416337,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-10-28,101.320000,106.530000,98.530000,106.200000,106.200000,439014,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-10-29,106.670000,108.920000,96.554000,100.120000,100.120000,368047,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-10-30,100.360000,101.640000,98.025000,99.350000,99.350000,317481,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-11-02,100.020000,110.350000,99.280100,109.630000,109.630000,464631,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-11-03,108.810000,111.730000,106.080000,109.660000,109.660000,418397,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-11-04,110.190000,112.700000,108.340000,108.570000,108.570000,334267,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-11-05,108.820000,109.560000,100.680000,103.040000,103.040000,552253,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-11-06,102.500000,105.880000,99.120000,103.740000,103.740000,415788,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-11-09,103.330000,105.910000,101.870000,102.330000,102.330000,420110,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-11-10,100.910000,100.910000,92.030100,97.430000,97.430000,602223,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-11-11,97.510000,102.539900,96.016800,96.340000,96.340000,226570,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-11-12,95.580000,99.540000,93.020000,94.710000,94.710000,328347,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-11-13,94.360000,98.420000,93.470000,95.700000,95.700000,276356,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-11-16,95.500000,97.890000,94.010000,96.390000,96.390000,217176,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-11-17,97.080000,103.760000,95.520000,99.940000,99.940000,359197,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-11-18,99.900000,104.960000,98.550000,103.760000,103.760000,259762,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-11-19,103.260000,105.190000,96.260000,97.710000,97.710000,245738,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-11-20,98.400000,98.990000,93.570000,93.920000,93.920000,471912,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-11-23,93.620000,101.460000,93.250000,98.750000,98.750000,323048,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-11-24,97.750000,98.175000,91.880000,94.460000,94.460000,418244,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-11-25,93.850000,96.470000,93.780000,94.930000,94.930000,312512,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-11-27,95.840000,101.650000,95.500000,100.820000,100.820000,135218,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-11-30,100.910000,100.910000,95.770000,98.320000,98.320000,231238,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-12-01,101.020000,103.876000,98.400000,102.350000,102.350000,332064,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-12-02,102.000000,102.000000,96.830000,98.450000,98.450000,471865,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-12-03,98.900000,101.500000,95.370000,95.890000,95.890000,573176,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-12-04,94.890000,100.840000,92.730000,100.280000,100.280000,687681,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-12-07,100.220000,101.700000,96.060000,97.870000,97.870000,573776,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-12-08,96.220000,104.650000,94.380000,104.340000,104.340000,486638,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-12-09,103.680000,104.220000,101.110000,102.690000,102.690000,518198,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-12-10,102.250000,103.000000,96.320000,100.790000,100.790000,529613,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-12-11,98.060000,101.430000,96.520000,98.180000,98.180000,335723,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-12-14,98.600000,102.660000,97.580000,101.910000,101.910000,249366,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-12-15,102.910000,106.290000,102.070000,105.400000,105.400000,282773,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-12-16,106.610000,111.680000,106.610000,111.430000,111.430000,365164,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-12-17,112.000000,113.150000,107.990000,110.370000,110.370000,281710,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-12-18,109.720000,112.095000,108.450000,109.870000,109.870000,1025863,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-12-21,110.970000,116.370000,110.000000,113.160000,113.160000,398697,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-12-22,115.790000,115.880000,110.020100,113.100000,113.100000,258409,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-12-23,114.010000,116.560000,112.370000,114.310000,114.310000,220625,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-12-24,114.330000,114.890000,112.240000,113.840000,113.840000,138488,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-12-28,112.660000,114.615000,109.800000,113.260000,113.260000,200035,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-12-29,114.450000,116.480000,113.480000,116.200000,116.200000,288450,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-12-30,116.350000,117.120000,112.720000,113.030000,113.030000,276673,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2015-12-31,112.640000,116.100000,111.730000,112.180000,112.180000,317178,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-01-04,108.800000,110.060000,101.540000,101.860000,101.860000,544507,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-01-05,102.000000,102.750000,97.030000,98.930000,98.930000,350492,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-01-06,95.690000,96.270000,91.780000,94.030000,94.030000,420631,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-01-07,90.970000,94.140000,89.160000,93.030000,93.030000,665091,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-01-08,93.140000,94.400000,86.200000,86.440000,86.440000,499905,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-01-11,87.160000,87.636900,76.880000,80.150000,80.150000,719024,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-01-12,82.850000,92.160000,79.470000,86.510000,86.510000,955778,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-01-13,87.320000,88.845500,75.550000,76.820000,76.820000,901814,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-01-14,78.170000,82.390000,70.490000,82.300000,82.300000,666800,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-01-15,78.130000,80.830000,76.290100,79.630000,79.630000,697263,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-01-19,81.160000,82.618600,69.260000,71.520000,71.520000,667360,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-01-20,70.050000,78.570000,65.750000,77.960000,77.960000,771423,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-01-21,78.960000,82.940000,73.530000,74.710000,74.710000,566671,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-01-22,76.860000,77.900000,73.370000,75.390000,75.390000,477589,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-01-25,75.180000,80.380000,74.690000,76.890000,76.890000,604162,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-01-26,77.360000,78.410000,70.000000,73.670000,73.670000,592789,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-01-27,73.650000,75.209600,64.170000,64.830000,64.830000,1201291,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-01-28,65.880000,66.710000,58.470000,61.070000,61.070000,994379,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-01-29,60.820000,63.780000,54.000000,56.150000,56.150000,1552403,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-02-01,56.570000,62.330000,54.855000,62.010000,62.010000,957451,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-02-02,60.810000,63.250000,59.420000,60.780000,60.780000,1124346,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-02-03,60.960000,61.110000,51.520000,58.460000,58.460000,1167450,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-02-04,57.890000,59.342000,52.020000,54.260000,54.260000,1258745,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-02-05,54.150000,56.155000,53.110100,53.850000,53.850000,674878,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-02-08,52.280000,53.850000,49.230000,50.720000,50.720000,884604,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-02-09,49.700000,54.630000,49.000000,51.640000,51.640000,1220296,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-02-10,52.190000,56.975000,50.360000,53.240000,53.240000,1073799,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-02-11,51.480000,54.440000,50.010000,53.440000,53.440000,515394,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-02-12,54.330000,55.180000,51.050000,54.770000,54.770000,735789,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-02-16,55.800000,58.900000,55.090000,57.890000,57.890000,676411,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-02-17,59.080000,63.460000,57.500000,61.500000,61.500000,726545,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-02-18,61.860000,63.670000,59.060000,60.520000,60.520000,779146,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-02-19,60.470000,64.840000,59.090000,63.270000,63.270000,486429,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-02-22,64.110000,65.950000,62.390000,63.720000,63.720000,673495,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-02-23,62.740000,64.190000,60.650000,60.830000,60.830000,745927,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-02-24,60.020000,62.990000,58.240000,62.740000,62.740000,496225,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-02-25,62.700000,64.970000,60.030100,60.850000,60.850000,639083,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-02-26,60.520000,63.870000,59.110000,62.300000,62.300000,589735,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-02-29,62.560000,64.770000,60.040000,60.990000,60.990000,866729,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-03-01,61.630000,64.850000,59.460000,64.700000,64.700000,814697,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-03-02,64.000000,70.000000,63.525000,67.780000,67.780000,980970,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-03-03,67.700000,68.650000,62.600000,63.380000,63.380000,618718,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-03-04,64.170000,65.190000,62.000000,62.740000,62.740000,660919,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-03-07,62.240000,66.380000,60.530000,65.820000,65.820000,650416,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-03-08,66.500000,67.000000,61.520000,61.900000,61.900000,806834,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-03-09,62.350000,62.930000,57.995000,58.610000,58.610000,931271,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-03-10,59.090000,61.028600,53.250000,54.950000,54.950000,965694,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-03-11,56.010000,60.600000,55.000000,60.000000,60.000000,842161,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-03-14,59.930000,61.900000,58.030000,58.700000,58.700000,647937,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-03-15,57.770000,58.170000,53.590000,54.730000,54.730000,529434,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-03-16,54.220000,55.680000,52.100000,53.430000,53.430000,562031,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-03-17,53.440000,54.776800,50.220000,54.280000,54.280000,679749,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-03-18,54.630000,57.620000,51.015000,56.320000,56.320000,1242478,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-03-21,55.790000,58.610000,55.430000,57.690000,57.690000,928210,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-03-22,57.270000,63.880000,57.270000,62.420000,62.420000,941986,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-03-23,62.090000,63.720000,58.490000,58.800000,58.800000,1023133,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-03-24,58.400000,61.970000,56.200300,59.020000,59.020000,557464,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-03-28,59.600000,60.720000,56.640000,56.810000,56.810000,480059,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-03-29,56.820000,59.360000,54.300000,59.130000,59.130000,573915,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-03-30,59.890000,62.199000,57.170000,57.300000,57.300000,796196,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-03-31,57.800000,64.360000,57.065000,63.310000,63.310000,617706,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-04-01,63.150000,66.960000,62.281600,66.460000,66.460000,519412,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-04-04,66.930000,70.480000,66.135000,67.620000,67.620000,759636,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-04-05,66.960000,70.780000,66.400000,67.620000,67.620000,549607,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-04-06,67.800000,74.960000,67.460000,73.510000,73.510000,667891,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-04-07,72.620000,78.130000,69.744600,70.140000,70.140000,616896,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-04-08,71.580000,72.000000,66.750000,70.650000,70.650000,597164,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-04-11,71.070000,71.070000,66.800000,66.980000,66.980000,456898,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-04-12,66.800000,69.590000,65.080000,69.250000,69.250000,462477,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-04-13,69.480000,71.720000,67.950000,71.340000,71.340000,344663,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-04-14,71.650000,71.910000,68.400000,70.940000,70.940000,367835,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-04-15,70.740000,71.500000,68.800000,70.850000,70.850000,281803,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-04-18,70.360000,73.830000,69.440000,73.700000,73.700000,440420,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-04-19,73.450000,73.730000,69.590000,69.860000,69.860000,598248,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-04-20,70.390000,71.420000,68.710000,70.510000,70.510000,386368,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-04-21,71.520000,75.480000,70.065000,75.410000,75.410000,528503,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-04-22,75.730000,76.410000,72.440000,76.020000,76.020000,454567,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-04-25,76.310000,76.969900,72.970000,73.190000,73.190000,427997,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-04-26,72.570000,72.620000,70.450000,70.880000,70.880000,404946,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-04-27,71.020000,71.020000,67.650000,69.580000,69.580000,426006,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-04-28,69.330000,70.720000,67.560000,68.000000,68.000000,372587,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-04-29,67.770000,69.220000,65.051000,67.620000,67.620000,462687,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-05-02,67.750000,69.580000,65.540000,69.460000,69.460000,405829,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-05-03,68.770000,69.710000,65.370000,65.560000,65.560000,573470,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-05-04,65.460000,66.370000,62.510000,63.090000,63.090000,586149,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-05-05,63.600000,63.600000,59.880000,62.450000,62.450000,413886,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-05-06,61.610000,64.850000,60.400000,63.160000,63.160000,480812,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-05-09,63.510000,66.060000,61.910000,64.360000,64.360000,524728,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-05-10,62.440000,65.460000,59.850000,63.550000,63.550000,669902,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-05-11,63.680000,64.529900,59.200000,59.430000,59.430000,672243,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-05-12,59.990000,60.600000,56.250000,58.560000,58.560000,569900,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-05-13,58.200000,60.610000,57.410000,59.260000,59.260000,329083,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-05-16,59.380000,62.120000,58.710000,59.490000,59.490000,570191,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-05-17,59.170000,61.200000,57.850000,58.880000,58.880000,632103,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-05-18,58.440000,63.300000,58.440000,63.180000,63.180000,415299,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-05-19,62.870000,64.590000,60.290100,61.460000,61.460000,560195,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-05-20,61.350000,64.239200,60.440000,64.010000,64.010000,550482,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-05-23,64.090000,67.090000,63.700000,65.190000,65.190000,417758,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-05-24,65.950000,69.190000,64.650000,68.280000,68.280000,696474,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-05-25,68.540000,71.105000,67.760000,68.590000,68.590000,643318,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-05-26,68.390000,70.859900,67.270000,69.530000,69.530000,483672,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-05-27,69.120000,69.550000,67.230000,68.570000,68.570000,536978,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-05-31,69.720000,74.680000,69.720000,73.100000,73.100000,1335001,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-06-01,72.400000,73.700000,70.260000,70.570000,70.570000,685680,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-06-02,70.480000,74.970000,70.250000,73.690000,73.690000,934096,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-06-03,73.050000,73.050000,67.550000,69.530000,69.530000,722519,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-06-06,69.260000,73.160000,66.320000,72.950000,72.950000,641167,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-06-07,71.670000,71.855000,68.620000,70.170000,70.170000,687480,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-06-08,70.800000,71.585000,69.120000,71.280000,71.280000,643510,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-06-09,70.330000,71.930000,65.690000,65.850000,65.850000,733794,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-06-10,65.440000,65.475000,61.500000,61.580000,61.580000,980754,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-06-13,61.290000,62.200000,59.160000,60.010000,60.010000,765689,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-06-14,59.890000,61.920000,59.735000,61.000000,61.000000,804568,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-06-15,61.590000,63.860000,61.020000,62.640000,62.640000,843930,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-06-16,62.160000,62.160000,59.160000,59.760000,59.760000,666519,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-06-17,58.740000,58.825000,54.720000,54.990000,54.990000,1346577,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-06-20,56.280000,57.150000,54.090000,54.500000,54.500000,978756,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-06-21,54.860000,54.860000,51.140000,52.030000,52.030000,1099151,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-06-22,51.940000,54.990000,50.270000,52.400000,52.400000,895655,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-06-23,52.990000,53.529900,50.810000,51.950000,51.950000,816359,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-06-24,48.830000,50.240000,48.520000,49.170000,49.170000,1024677,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-06-27,48.180000,49.650000,46.520000,47.260000,47.260000,985744,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-06-28,48.490000,50.970000,48.380000,50.730000,50.730000,1158129,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-06-29,52.160000,52.179900,48.880000,49.750000,49.750000,887249,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-06-30,49.680000,50.605000,48.210000,48.910000,48.910000,692033,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-07-01,49.190000,52.200000,49.040000,51.710000,51.710000,547514,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-07-05,51.000000,51.000000,49.060000,49.990000,49.990000,673933,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-07-06,49.540000,51.950000,49.250100,51.760000,51.760000,488671,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-07-07,52.970000,53.880000,52.160000,52.500000,52.500000,846917,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-07-08,52.550000,54.150000,51.750000,53.350000,53.350000,513556,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-07-11,53.730000,55.369400,52.680000,52.880000,52.880000,691253,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-07-12,54.430000,57.075000,53.316000,54.400000,54.400000,1042849,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-07-13,54.600000,55.520000,50.640000,50.850000,50.850000,871718,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-07-14,52.190000,52.920000,48.330000,49.540000,49.540000,1054531,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-07-15,51.140000,53.780000,49.970000,53.170000,53.170000,1060029,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-07-18,53.460000,54.390000,51.873800,53.530000,53.530000,700260,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-07-19,53.350000,53.750000,50.250000,50.550000,50.550000,771558,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-07-20,50.800000,53.780000,50.580000,52.770000,52.770000,679465,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-07-21,53.000000,53.985500,51.500000,52.320000,52.320000,443590,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-07-22,52.710000,53.960000,51.890000,53.730000,53.730000,593143,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-07-25,53.930000,54.580000,53.000000,54.220000,54.220000,375222,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-07-26,53.950000,58.168400,53.650000,57.190000,57.190000,935240,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-07-27,57.490000,61.670000,57.490000,61.430000,61.430000,1211660,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-07-28,61.270000,63.170000,60.330000,61.010000,61.010000,581444,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-07-29,61.090000,63.500000,60.850000,63.280000,63.280000,631547,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-08-01,63.440000,65.120000,62.693700,63.530000,63.530000,557303,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-08-02,63.220000,64.920000,61.870000,63.330000,63.330000,420305,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-08-03,63.140000,65.110000,62.650000,65.040000,65.040000,300267,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-08-04,65.400000,67.590000,63.880000,64.240000,64.240000,331239,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-08-05,64.590000,66.620000,64.050000,66.400000,66.400000,267744,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-08-08,66.410000,67.010000,64.040000,65.350000,65.350000,396056,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-08-09,66.010000,66.240000,62.470000,64.970000,64.970000,456142,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-08-10,64.720000,64.990000,62.750000,63.280000,63.280000,420686,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-08-11,63.720000,69.360000,63.500000,68.350000,68.350000,1028111,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-08-12,68.000000,68.290000,64.520000,66.540000,66.540000,645250,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-08-15,66.860000,68.725000,66.550000,67.590000,67.590000,433912,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-08-16,67.550000,67.550000,64.870000,65.660000,65.660000,448032,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-08-17,65.690000,65.790000,64.570000,65.070000,65.070000,411519,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-08-18,65.140000,66.070000,64.180000,65.840000,65.840000,346457,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-08-19,65.670000,67.250000,65.170000,66.000000,66.000000,338647,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-08-22,66.990000,68.270000,66.000000,68.100000,68.100000,776411,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-08-23,68.530000,70.600000,67.940000,69.360000,69.360000,856126,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-08-24,69.070000,69.999900,63.320000,64.100000,64.100000,905180,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-08-25,64.150000,65.380000,62.010000,63.200000,63.200000,547743,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-08-26,62.910000,67.750000,62.910000,65.500000,65.500000,703934,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-08-29,65.650000,66.330000,64.100000,65.020000,65.020000,353069,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-08-30,64.890000,67.500000,64.730000,66.810000,66.810000,544671,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-08-31,66.670000,66.810000,65.392000,65.920000,65.920000,514484,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-09-01,66.260000,66.720000,64.990000,66.275000,66.275000,280763,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-09-02,66.620000,67.160000,64.570000,65.130000,65.130000,353003,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-09-06,65.660000,69.300000,65.290000,67.380000,67.380000,594279,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-09-07,67.640000,69.950000,67.260000,68.030000,68.030000,401409,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-09-08,68.120000,69.780000,67.280000,69.650000,69.650000,411959,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-09-09,68.520000,69.600000,66.320000,66.410000,66.410000,493590,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-09-12,65.670000,71.590000,65.670000,71.390000,71.390000,561643,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-09-13,70.570000,71.210000,67.555000,69.880000,69.880000,568537,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-09-14,70.230000,72.360000,69.530000,72.130000,72.130000,546702,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-09-15,72.300000,74.730000,71.710000,74.190000,74.190000,522112,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-09-16,73.810000,77.270000,72.920000,77.120000,77.120000,846423,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-09-19,78.320000,81.400000,75.860000,76.580000,76.580000,1159582,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-09-20,77.620000,78.622800,75.160000,75.950000,75.950000,851531,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-09-21,76.560000,76.895000,71.130000,73.790000,73.790000,1345190,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-09-22,74.610000,75.190000,72.850000,74.050000,74.050000,398898,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-09-23,74.340000,75.309900,72.500000,72.600000,72.600000,511138,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-09-26,72.130000,73.075200,70.765000,71.250000,71.250000,342069,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-09-27,71.090000,72.820000,70.510000,72.740000,72.740000,428754,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-09-28,72.710000,73.830000,70.270000,71.560000,71.560000,449679,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-09-29,71.260000,71.835000,68.460000,68.580000,68.580000,685645,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-09-30,68.660000,72.420000,68.150000,70.940000,70.940000,460886,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-10-03,70.500000,71.915000,68.860000,70.850000,70.850000,478058,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-10-04,71.060000,71.930000,69.765000,70.030000,70.030000,291822,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-10-05,70.710000,75.480000,70.150000,72.850000,72.850000,652722,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-10-06,71.820000,72.480000,69.205000,69.760000,69.760000,690138,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-10-07,69.660000,71.850000,68.510000,70.840000,70.840000,583793,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-10-10,71.880000,73.550000,71.210000,72.920000,72.920000,365835,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-10-11,72.070000,73.274500,69.500000,70.040000,70.040000,558382,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-10-12,70.050000,70.960000,64.880000,65.510000,65.510000,696565,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-10-13,64.560000,67.200000,64.260000,66.180000,66.180000,611395,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-10-14,66.750000,67.290000,61.540000,61.570000,61.570000,598673,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-10-17,61.780000,62.075000,59.960000,60.750000,60.750000,424007,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-10-18,61.730000,62.860000,61.430000,62.140000,62.140000,310383,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-10-19,62.280000,62.810000,60.280000,61.550000,61.550000,390180,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-10-20,62.220000,66.840000,61.710000,66.610000,66.610000,854586,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-10-21,66.470000,67.100000,65.110000,66.400000,66.400000,1233503,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-10-24,66.910000,68.360000,65.590000,65.970000,65.970000,381274,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-10-25,66.020000,66.715000,62.980000,63.050000,63.050000,345730,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-10-26,62.820000,64.432100,61.980000,63.130000,63.130000,507928,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-10-27,64.130000,64.770000,62.420000,62.770000,62.770000,489404,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-10-28,62.440000,64.390000,59.290000,62.620000,62.620000,600217,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-10-31,62.730000,63.220000,58.880000,58.990000,58.990000,423198,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-11-01,59.470000,61.120000,58.100000,60.220000,60.220000,573699,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-11-02,59.830000,59.990000,57.680000,58.040000,58.040000,535463,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-11-03,58.090000,58.090000,52.600000,52.700000,52.700000,868752,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-11-04,53.250000,56.340000,53.250000,55.250000,55.250000,791949,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-11-07,56.550000,59.360000,55.250000,58.540000,58.540000,856688,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-11-08,57.540000,61.760000,56.320000,61.170000,61.170000,951500,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-11-09,67.270000,76.310000,64.130000,71.720000,71.720000,1323122,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-11-10,72.450000,80.960000,72.450000,78.720000,78.720000,1639655,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-11-11,74.360000,82.480000,73.510000,82.060000,82.060000,1333903,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-11-14,79.690000,83.670000,76.350000,81.740000,81.740000,1132139,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-11-15,80.870000,83.110000,78.491100,81.430000,81.430000,702209,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-11-16,81.210000,83.690000,77.030000,77.840000,77.840000,589657,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-11-17,78.470000,81.690000,76.120000,81.420000,81.420000,506997,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-11-18,81.180000,83.000000,79.670000,82.720000,82.720000,469384,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-11-21,82.810000,84.840000,80.940000,84.660000,84.660000,438314,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-11-22,84.970000,85.520000,80.110000,80.750000,80.750000,610655,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-11-23,78.570000,86.100000,76.940000,85.810000,85.810000,572702,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-11-25,85.300000,86.770000,83.000000,86.740000,86.740000,247843,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-11-28,86.270000,86.270000,80.450000,81.670000,81.670000,711209,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-11-29,82.090000,84.880000,79.310000,84.190000,84.190000,574741,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-11-30,85.000000,85.292000,77.550000,78.290000,78.290000,898067,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-12-01,79.290000,79.755000,74.590000,74.690000,74.690000,751197,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-12-02,74.370000,77.455000,74.320000,74.550000,74.550000,518474,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-12-05,76.030000,79.780000,75.480000,76.830000,76.830000,531429,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-12-06,77.060000,77.638000,73.760000,76.920000,76.920000,585835,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-12-07,75.580000,76.460000,71.220100,71.330000,71.330000,664815,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-12-08,70.990000,72.500000,68.470000,71.960000,71.960000,770580,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-12-09,72.660000,75.010000,70.030000,70.740000,70.740000,539833,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-12-12,70.210000,71.700000,69.310000,70.590000,70.590000,524506,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-12-13,71.480000,72.260000,69.140000,69.510000,69.510000,562228,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-12-14,69.600000,71.250000,69.210000,70.480000,70.480000,386211,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-12-15,70.920000,72.530000,69.320000,72.340000,72.340000,548127,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-12-16,72.250000,74.790000,71.360000,72.250000,72.250000,1267456,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-12-19,71.910000,73.500000,71.170000,71.340000,71.340000,418110,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-12-20,72.080000,73.480000,71.670000,72.950000,72.950000,305334,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-12-21,73.110000,74.870000,71.190000,72.220000,72.220000,346583,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-12-22,72.480000,72.980000,70.420000,71.280000,71.280000,288919,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-12-23,71.220000,74.030000,70.760000,73.790000,73.790000,497493,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-12-27,74.270000,75.900000,73.440000,73.860000,73.860000,341313,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-12-28,74.020000,74.050000,71.100000,71.220000,71.220000,343726,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-12-29,71.360000,72.340000,69.450000,70.160000,70.160000,253319,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2016-12-30,70.280000,71.160000,69.660000,70.310000,70.310000,241166,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-01-03,71.380000,72.570000,69.390000,69.970000,69.970000,320061,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-01-04,70.310000,76.210000,70.310000,75.450000,75.450000,465564,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-01-05,75.600000,77.050000,73.610000,76.370000,76.370000,390271,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-01-06,76.250000,78.595000,75.790000,76.970000,76.970000,408665,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-01-09,77.210000,77.765000,74.210000,74.770000,74.770000,603297,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-01-10,75.230000,75.940000,72.360000,73.850000,73.850000,364643,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-01-11,73.600000,74.335000,69.770000,71.100000,71.100000,574377,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-01-12,70.000000,74.180000,69.490000,72.970000,72.970000,315225,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-01-13,72.930000,75.395000,72.420000,73.010000,73.010000,371415,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-01-17,72.190000,72.190000,69.030000,69.190000,69.190000,544897,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-01-18,69.600000,70.890000,68.300000,70.750000,70.750000,383012,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-01-19,70.590000,71.250000,69.300000,69.860000,69.860000,298983,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-01-20,70.020000,70.500000,68.300000,68.700000,68.700000,389875,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-01-23,68.650000,69.140000,67.230000,68.390000,68.390000,350990,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-01-24,68.630000,70.240000,66.660000,70.045000,70.045000,358223,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-01-25,70.950000,71.380000,69.140000,69.860000,69.860000,213878,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-01-26,69.890000,70.810000,68.210000,68.660000,68.660000,219064,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-01-27,68.720000,69.980000,68.520100,69.150000,69.150000,184061,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-01-30,68.650000,68.845000,66.055000,67.800000,67.800000,241696,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-01-31,67.030000,75.099900,66.560000,75.010000,75.010000,539939,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-02-01,75.570000,76.020000,73.685000,75.000000,75.000000,508658,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-02-02,74.450000,76.190000,73.540000,73.880000,73.880000,378735,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-02-03,74.490000,74.750000,73.720000,74.110000,74.110000,485622,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-02-06,73.890000,74.480000,72.600000,73.990000,73.990000,397826,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-02-07,73.990000,75.000000,72.540000,72.910000,72.910000,423782,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-02-08,72.370000,72.840000,71.030000,71.380000,71.380000,425702,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-02-09,71.520000,73.890000,71.520000,73.660000,73.660000,1054966,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-02-10,73.870000,74.500000,72.260000,73.900000,73.900000,371858,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-02-13,74.500000,75.500000,74.150000,74.770000,74.770000,359716,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-02-14,74.680000,76.340000,73.910000,76.240000,76.240000,284327,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-02-15,76.120000,77.200000,74.980000,76.760000,76.760000,347308,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-02-16,77.580000,77.580000,74.940000,76.820000,76.820000,432478,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-02-17,78.250000,78.250000,72.875000,76.910000,76.910000,708333,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-02-21,77.230000,78.710000,76.390000,76.920000,76.920000,453213,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-02-22,77.000000,78.820000,76.530000,78.180000,78.180000,362662,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-02-23,78.290000,78.470000,75.030000,76.880000,76.880000,468934,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-02-24,75.900000,77.570000,73.690000,77.470000,77.470000,280005,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-02-27,77.550000,85.580000,77.310000,85.160000,85.160000,1120337,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-02-28,84.650000,87.223000,83.086000,85.080000,85.080000,728383,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-03-01,86.930000,89.270000,85.210000,88.800000,88.800000,790714,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-03-02,89.000000,91.345000,85.220000,85.460000,85.460000,533299,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-03-03,85.680000,88.280000,85.560000,88.250000,88.250000,412107,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-03-06,87.570000,88.670000,86.430000,87.710000,87.710000,255117,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-03-07,86.500000,88.640000,84.860000,85.150000,85.150000,449896,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-03-08,85.310000,87.280000,84.260000,85.780000,85.780000,303106,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-03-09,85.970000,87.320000,85.200000,86.280000,86.280000,228836,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-03-10,87.160000,87.160000,84.790000,85.970000,85.970000,263409,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-03-13,85.630000,85.680000,84.140000,84.220000,84.220000,269361,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-03-14,83.380000,85.185000,82.560000,84.390000,84.390000,318461,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-03-15,84.730000,88.590000,82.530000,88.110000,88.110000,482937,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-03-16,87.670000,88.950000,85.130000,85.565000,85.565000,362146,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-03-17,84.480000,86.140000,84.010000,84.610000,84.610000,944044,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-03-20,84.730000,85.740000,83.400000,85.070000,85.070000,290287,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-03-21,85.740000,85.775000,77.450000,77.720000,77.720000,463475,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-03-22,77.730000,79.920000,77.250000,78.360000,78.360000,591403,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-03-23,73.110000,73.880000,70.510000,71.990000,71.990000,2164045,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-03-24,72.380000,72.380000,67.910000,70.320000,70.320000,1376799,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-03-27,69.000000,71.410000,68.470000,69.980000,69.980000,585539,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-03-28,69.870000,70.790000,66.850000,67.660000,67.660000,596265,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-03-29,66.980000,67.960000,66.600000,66.720000,66.720000,516066,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-03-30,66.590000,67.440000,65.550000,67.300000,67.300000,543441,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-03-31,67.300000,68.450000,66.680000,67.780000,67.780000,667394,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-04-03,67.420000,68.460000,64.635000,64.700000,64.700000,699128,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-04-04,64.630000,66.130000,64.411000,64.970000,64.970000,511708,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-04-05,65.290000,65.740000,61.220000,61.710000,61.710000,639888,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-04-06,61.150000,63.259000,58.320000,58.590000,58.590000,947930,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-04-07,58.440000,60.110000,58.060000,58.830000,58.830000,422308,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-04-10,58.940000,59.360000,57.370000,57.510000,57.510000,301578,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-04-11,57.340000,58.965000,56.170000,57.690000,57.690000,459616,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-04-12,57.890000,58.710000,57.200000,57.660000,57.660000,364294,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-04-13,57.400000,60.410000,57.050000,60.280000,60.280000,534302,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-04-17,59.690000,61.460000,59.605000,61.450000,61.450000,425323,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-04-18,60.920000,63.940000,59.450000,60.080000,60.080000,700243,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-04-19,65.050000,66.170000,60.100000,60.890000,60.890000,4408257,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-04-20,60.850000,62.530000,59.620000,62.040000,62.040000,887963,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-04-21,61.740000,62.398000,59.950000,60.570000,60.570000,669457,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-04-24,61.420000,62.160000,61.030000,61.310000,61.310000,327281,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-04-25,62.340000,65.160000,62.050000,65.020000,65.020000,741940,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-04-26,65.090000,66.330000,64.690000,65.680000,65.680000,344683,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-04-27,65.800000,66.130000,64.510000,64.540000,64.540000,302449,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-04-28,64.760000,65.010000,63.450000,64.390000,64.390000,230611,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-05-01,64.640000,64.650000,62.500000,63.420000,63.420000,445649,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-05-02,63.380000,64.150000,59.900000,61.000000,61.000000,728291,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-05-03,60.720000,61.280000,58.350000,59.910000,59.910000,649302,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-05-04,60.320000,61.540000,60.050000,61.220000,61.220000,524769,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-05-05,62.250000,62.750000,59.330000,61.080000,61.080000,585443,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-05-08,60.690000,61.000000,59.420000,60.090000,60.090000,353126,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-05-09,60.620000,62.080000,59.830000,61.380000,61.380000,302034,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-05-10,60.980000,61.440000,59.060000,59.390000,59.390000,270614,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-05-11,58.900000,59.520000,57.055000,57.690000,57.690000,455288,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-05-12,57.640000,58.660000,57.140000,57.950000,57.950000,350683,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-05-15,58.180000,59.235000,57.660000,58.860000,58.860000,202525,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-05-16,58.170000,59.590000,58.170000,59.380000,59.380000,169517,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-05-17,58.080000,59.490000,57.680000,58.310000,58.310000,364503,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-05-18,58.290000,59.800000,58.230000,59.010000,59.010000,251491,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-05-19,59.100000,59.540000,57.390000,57.470000,57.470000,280283,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-05-22,57.600000,57.710000,56.430000,57.380000,57.380000,231989,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-05-23,57.640000,57.750000,56.300000,57.550000,57.550000,260074,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-05-24,57.540000,61.040000,56.750000,60.010000,60.010000,441504,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-05-25,60.270000,60.610000,57.980000,58.520000,58.520000,313139,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-05-26,57.450000,58.610000,55.550000,55.910000,55.910000,304326,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-05-30,55.750000,56.000000,52.960000,53.010000,53.010000,320937,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-05-31,53.420000,54.540000,51.670000,53.850000,53.850000,277222,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-06-01,54.210000,57.710000,54.025000,56.610000,56.610000,408715,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-06-02,56.640000,57.870000,56.220000,56.840000,56.840000,427774,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-06-05,57.300000,57.900000,55.100000,56.230000,56.230000,315533,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-06-06,55.490000,58.600000,55.310000,57.270000,57.270000,600346,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-06-07,57.660000,58.118000,55.450000,55.780000,55.780000,343413,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-06-08,55.410000,57.000000,55.230000,56.930000,56.930000,298769,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-06-09,57.090000,59.760000,56.135000,57.310000,57.310000,558397,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-06-12,57.370000,57.920000,54.150000,54.770000,54.770000,724775,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-06-13,54.970000,58.700000,54.390000,58.670000,58.670000,615681,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-06-14,58.760000,63.040000,57.920000,61.730000,61.730000,661851,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-06-15,61.210000,63.680000,60.180000,61.850000,61.850000,378363,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-06-16,61.160000,63.035000,60.600000,62.480000,62.480000,926121,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-06-19,62.780000,65.070000,62.413000,63.870000,63.870000,354917,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-06-20,64.000000,67.530000,62.900000,63.380000,63.380000,417670,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-06-21,63.860000,66.530000,63.220000,66.400000,66.400000,462878,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-06-22,66.400000,67.980000,63.080000,65.660000,65.660000,561761,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-06-23,65.620000,66.910000,63.700000,66.420000,66.420000,515528,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-06-26,66.420000,67.290000,65.010000,65.290000,65.290000,247874,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-06-27,65.360000,65.630000,60.330000,60.610000,60.610000,453994,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-06-28,61.290000,63.960000,59.980000,63.090000,63.090000,342548,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-06-29,63.150000,63.260000,60.361000,61.880000,61.880000,296391,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-06-30,61.980000,62.635000,60.790000,62.110000,62.110000,310994,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-07-03,62.300000,63.950000,61.600000,63.810000,63.810000,164446,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-07-05,63.610000,66.850000,62.730000,66.720000,66.720000,389211,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-07-06,66.050000,66.230000,62.970000,63.280000,63.280000,269821,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-07-07,63.950000,64.245000,63.120000,63.920000,63.920000,149311,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-07-10,63.770000,64.095000,61.180000,61.480000,61.480000,238493,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-07-11,61.580000,64.070000,61.480000,63.760000,63.760000,186937,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-07-12,64.250000,64.710000,62.940000,63.420000,63.420000,226237,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-07-13,63.420000,65.580000,61.580000,64.830000,64.830000,244836,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-07-14,64.800000,65.710000,64.220000,64.360000,64.360000,182157,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-07-17,64.880000,69.743000,64.880000,66.290000,66.290000,396015,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-07-18,66.240000,67.325000,65.320000,66.830000,66.830000,180737,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-07-19,67.570000,69.420000,67.290000,68.060000,68.060000,273956,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-07-20,68.350000,71.340000,67.610000,70.990000,70.990000,316073,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-07-21,71.550000,71.990000,69.310000,70.060000,70.060000,231294,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-07-24,70.060000,71.850000,69.440000,71.590000,71.590000,286733,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-07-25,71.500000,71.505000,69.280000,70.840000,70.840000,226566,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-07-26,70.950000,71.390000,70.010000,70.830000,70.830000,197504,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-07-27,71.520000,71.770000,66.900000,67.740000,67.740000,295267,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-07-28,66.080000,67.880000,64.180000,66.990000,66.990000,317348,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-07-31,66.880000,67.690000,65.930000,66.320000,66.320000,183690,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-08-01,66.920000,68.098000,63.110000,63.340000,63.340000,299941,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-08-02,63.490000,63.610000,61.520000,62.590000,62.590000,201451,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-08-03,62.720000,63.720000,61.560000,62.590000,62.590000,215592,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-08-04,62.770000,63.680000,62.290000,63.300000,63.300000,165958,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-08-07,63.160000,64.470000,62.290000,64.070000,64.070000,126282,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-08-08,63.960000,65.930000,63.330000,64.140000,64.140000,203272,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-08-09,63.650000,65.055000,61.960000,62.780000,62.780000,124772,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-08-10,62.280000,62.360000,59.940000,60.120000,60.120000,234054,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-08-11,60.870000,60.930000,58.300000,59.440000,59.440000,223837,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-08-14,59.910000,61.000000,59.310000,60.790000,60.790000,164365,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-08-15,61.030000,61.590000,60.005700,60.980000,60.980000,143451,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-08-16,60.990000,62.510000,60.550000,61.340000,61.340000,145885,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-08-17,60.350000,61.775000,57.910000,57.950000,57.950000,210049,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-08-18,57.390000,58.200000,56.440000,56.510000,56.510000,262203,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-08-21,56.460000,56.960000,55.630000,56.910000,56.910000,142445,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-08-22,57.310000,59.040000,57.000000,58.850000,58.850000,136690,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-08-23,51.000000,52.340000,50.490000,51.020000,51.020000,1600391,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-08-24,51.120000,51.980000,51.105000,51.430000,51.430000,439253,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-08-25,51.610000,51.830000,51.010000,51.400000,51.400000,385069,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-08-28,52.050000,53.020000,51.450000,53.000000,53.000000,323258,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-08-29,52.200000,55.340000,52.060000,54.350000,54.350000,350231,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-08-30,54.940000,56.835000,54.690000,56.240000,56.240000,341089,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-08-31,55.750000,58.040000,55.190000,57.060000,57.060000,469333,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-09-01,57.500000,58.045000,56.110000,56.320000,56.320000,413672,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-09-05,56.170000,56.679900,53.665000,54.520000,54.520000,244774,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-09-06,54.660000,54.935000,51.370000,52.780000,52.780000,311320,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-09-07,51.960000,52.370000,49.965000,50.000000,50.000000,555338,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-09-08,49.980000,50.522000,49.565000,49.960000,49.960000,289681,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-09-11,51.030000,51.240000,49.980000,50.510000,50.510000,288416,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-09-12,50.660000,51.185000,49.751000,50.270000,50.270000,300339,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-09-13,50.340000,51.250000,49.610000,49.790000,49.790000,308977,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-09-14,51.000000,54.300000,50.380000,53.380000,53.380000,738018,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-09-15,53.540000,55.250000,53.000100,55.230000,55.230000,686260,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-09-18,55.170000,55.630000,52.810000,52.990000,52.990000,303274,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-09-19,52.920000,53.600000,51.440000,51.900000,51.900000,224754,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-09-20,51.880000,52.830000,51.570000,52.630000,52.630000,269269,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-09-21,52.870000,54.750000,51.990000,52.520000,52.520000,406929,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-09-22,52.320000,52.780000,51.480000,52.160000,52.160000,387647,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-09-25,52.500000,54.250000,52.080000,53.050000,53.050000,240223,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-09-26,52.890000,52.890000,51.860000,52.290000,52.290000,207410,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-09-27,52.500000,53.590000,52.500000,53.010000,53.010000,225187,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-09-28,53.230000,54.000000,52.680000,53.980000,53.980000,182440,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-09-29,53.880000,54.410000,52.900000,53.260000,53.260000,214198,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-10-02,53.670000,57.320000,53.550000,57.320000,57.320000,329796,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-10-03,58.000000,58.000000,55.140000,56.760000,56.760000,431542,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-10-04,56.440000,57.490000,55.439000,56.590000,56.590000,167082,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-10-05,56.580000,57.400000,55.380000,55.810000,55.810000,230975,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-10-06,55.680000,56.240000,53.670000,54.310000,54.310000,248680,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-10-09,54.600000,55.340000,53.570000,53.810000,53.810000,143101,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-10-10,54.200000,54.530000,53.540000,54.010000,54.010000,296653,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-10-11,54.110000,55.380000,53.510000,54.900000,54.900000,319822,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-10-12,54.890000,55.445000,54.060000,54.460000,54.460000,276977,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-10-13,54.180000,54.307000,53.320000,53.950000,53.950000,292909,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-10-16,54.250000,55.170000,53.730000,54.520000,54.520000,207533,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-10-17,54.330000,54.960000,53.340000,53.460000,53.460000,349637,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-10-18,53.750000,53.860000,52.280000,52.430000,52.430000,279339,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-10-19,52.630000,52.670000,50.630000,51.510000,51.510000,333867,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-10-20,52.020000,52.090000,50.360000,51.510000,51.510000,773252,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-10-23,52.080000,52.170000,50.360000,50.400000,50.400000,244658,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-10-24,50.410000,50.625000,48.520000,49.680000,49.680000,376903,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-10-25,49.610000,49.880000,47.550000,47.660000,47.660000,385542,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-10-26,47.550000,48.130000,45.040000,45.900000,45.900000,631764,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-10-27,45.930000,46.540000,44.750000,46.520000,46.520000,597931,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-10-30,46.030000,46.560000,44.558000,45.190000,45.190000,395460,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-10-31,45.670000,46.700000,44.660000,46.090000,46.090000,446829,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-11-01,47.000000,48.900000,46.830000,47.990000,47.990000,761524,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-11-02,47.660000,49.040000,47.275000,48.250000,48.250000,402825,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-11-03,47.470000,51.060000,47.470000,49.530000,49.530000,709442,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-11-06,49.080000,49.750000,46.900000,47.210000,47.210000,396812,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-11-07,47.550000,47.550000,44.720000,45.480000,45.480000,406277,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-11-08,45.110000,45.720000,44.450000,45.290000,45.290000,394104,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-11-09,44.930000,46.670000,44.800000,46.260000,46.260000,324562,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-11-10,46.350000,48.460000,46.010000,47.410000,47.410000,484030,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-11-13,47.240000,48.770000,47.010000,48.670000,48.670000,310079,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-11-14,48.240000,48.850000,44.020000,45.550000,45.550000,555577,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-11-15,44.900000,47.980000,44.030000,47.320000,47.320000,737056,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-11-16,47.500000,49.000000,47.010000,48.220000,48.220000,495510,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-11-17,47.900000,49.270000,46.350000,48.110000,48.110000,549088,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-11-20,48.110000,48.260000,47.100000,47.840000,47.840000,222785,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-11-21,48.140000,49.140000,47.615000,48.130000,48.130000,427080,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-11-22,48.550000,49.880000,48.360000,48.940000,48.940000,265575,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-11-24,49.270000,49.470000,48.320000,48.910000,48.910000,145319,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-11-27,49.020000,49.600000,47.240000,47.450000,47.450000,296917,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-11-28,47.650000,47.650000,45.805000,46.530000,46.530000,423828,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-11-29,46.760000,48.150000,46.460000,47.760000,47.760000,496154,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-11-30,48.000000,50.880000,47.005000,50.490000,50.490000,536926,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-12-01,50.060000,52.112000,48.961000,51.700000,51.700000,646045,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-12-04,53.000000,54.355000,51.140000,51.760000,51.760000,974813,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-12-05,51.910000,53.050000,49.310000,49.960000,49.960000,1218659,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-12-06,49.880000,50.930000,47.830000,48.780000,48.780000,478528,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-12-07,48.590000,48.660000,46.100000,46.170000,46.170000,558802,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-12-08,46.780000,47.510000,45.300000,45.570000,45.570000,494085,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-12-11,46.110000,46.690000,45.220000,45.240000,45.240000,404307,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-12-12,45.530000,45.640000,43.380100,44.510000,44.510000,514700,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-12-13,44.450000,45.430000,43.610000,45.190000,45.190000,330975,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-12-14,45.300000,45.850000,43.850000,44.020000,44.020000,303192,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-12-15,44.290000,45.620000,43.970000,44.680000,44.680000,699412,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-12-18,45.000000,45.800000,43.140000,43.540000,43.540000,404299,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-12-19,43.650000,47.470000,43.650000,46.610000,46.610000,798222,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-12-20,47.090000,48.220000,47.030000,47.960000,47.960000,485815,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-12-21,47.890000,49.060000,46.980000,47.950000,47.950000,405579,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-12-22,47.870000,48.420000,46.200000,48.030000,48.030000,354551,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-12-26,47.930000,48.770000,47.420000,48.310000,48.310000,249791,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-12-27,48.160000,48.540000,47.500000,47.590000,47.590000,197840,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-12-28,47.870000,47.920000,46.850000,46.970000,46.970000,232456,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2017-12-29,47.180000,47.180000,46.320000,46.380000,46.380000,284400,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-01-02,47.050000,49.440000,46.360000,49.290000,49.290000,466976,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-01-03,49.530000,51.640000,48.990000,50.310000,50.310000,482420,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-01-04,50.730000,53.390000,50.531100,51.000000,51.000000,545064,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-01-05,51.310000,52.015000,50.470000,50.810000,50.810000,374946,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-01-08,50.360000,51.020000,47.830000,48.240000,48.240000,465917,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-01-09,48.310000,49.655000,47.800000,49.070000,49.070000,252022,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-01-10,48.910000,49.380000,47.310000,49.060000,49.060000,339279,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-01-11,49.120000,49.120000,46.510000,48.170000,48.170000,375248,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-01-12,48.250000,49.120000,47.520000,47.800000,47.800000,343132,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-01-16,48.020000,48.760000,45.690100,45.810000,45.810000,358915,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-01-17,46.390000,48.230000,45.730000,47.770000,47.770000,564055,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-01-18,48.330000,48.620000,46.950000,47.250000,47.250000,417449,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-01-19,47.070000,49.370000,47.050000,49.160000,49.160000,609254,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-01-22,51.990000,56.030000,51.040000,53.390000,53.390000,1005851,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-01-23,51.640000,58.615000,51.640000,58.140000,58.140000,1634433,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-01-24,57.520000,60.895000,55.000000,58.520000,58.520000,3522227,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-01-25,59.110000,59.815000,57.360000,57.910000,57.910000,592026,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-01-26,57.940000,58.770000,55.550000,56.840000,56.840000,654705,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-01-29,56.830000,59.350000,56.830000,57.060000,57.060000,469120,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-01-30,56.090000,56.580000,54.790000,55.000000,55.000000,392327,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-01-31,54.940000,55.465000,53.260000,53.350000,53.350000,375048,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-02-01,53.170000,53.590000,50.300000,51.270000,51.270000,799382,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-02-02,50.840000,51.425000,49.020000,49.060000,49.060000,652200,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-02-05,48.420000,50.030000,47.800000,47.810000,47.810000,602701,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-02-06,46.490000,48.230000,46.025000,47.910000,47.910000,790989,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-02-07,47.530000,48.340000,45.930000,47.050000,47.050000,482683,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-02-08,47.320000,47.840000,44.280000,44.330000,44.330000,409831,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-02-09,44.500000,45.050000,41.670000,44.470000,44.470000,768477,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-02-12,44.520000,45.740000,43.360000,44.380000,44.380000,619593,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-02-13,43.830000,45.200000,42.570000,44.650000,44.650000,508675,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-02-14,44.210000,47.870000,44.210000,47.630000,47.630000,497344,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-02-15,48.010000,48.770000,46.300000,47.520000,47.520000,466570,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-02-16,47.380000,48.230000,46.590000,47.120000,47.120000,341273,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-02-20,47.040000,50.890000,46.521000,48.180000,48.180000,792072,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-02-21,46.610000,48.170000,43.260000,46.310000,46.310000,1183130,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-02-22,46.400000,50.350000,46.400000,47.650000,47.650000,537172,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-02-23,47.890000,48.360000,46.570000,47.860000,47.860000,530885,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-02-26,48.370000,50.410000,47.930000,49.930000,49.930000,410620,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-02-27,49.680000,50.370000,48.570000,48.660000,48.660000,310011,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-02-28,48.810000,49.950000,47.800000,47.810000,47.810000,301934,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-03-01,48.290000,49.000000,46.610000,48.430000,48.430000,571294,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-03-02,47.930000,51.000000,47.570000,50.590000,50.590000,479060,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-03-05,50.100000,53.130000,50.100000,52.780000,52.780000,519189,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-03-06,52.790000,53.750000,51.195000,52.660000,52.660000,507813,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-03-07,53.200000,53.730000,51.360000,52.820000,52.820000,495767,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-03-08,52.790000,53.860000,52.010000,52.920000,52.920000,318143,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-03-09,53.520000,54.500000,52.230000,53.800000,53.800000,380671,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-03-12,53.910000,54.670000,53.100000,53.800000,53.800000,279398,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-03-13,54.360000,55.060000,53.750000,54.430000,54.430000,386896,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-03-14,54.970000,55.217000,51.380000,54.400000,54.400000,367163,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-03-15,54.630000,54.980000,52.710000,52.820000,52.820000,586453,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-03-16,52.800000,53.070000,51.030000,51.260000,51.260000,1559810,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-03-19,50.540000,52.420000,49.660000,50.200000,50.200000,568443,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-03-20,50.700000,51.290000,50.010000,50.870000,50.870000,337043,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-03-21,50.910000,52.490000,50.510000,52.330000,52.330000,280935,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-03-22,52.220000,54.000000,51.230000,51.360000,51.360000,294021,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-03-23,51.490000,52.380000,49.870000,50.000000,50.000000,349344,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-03-26,50.720000,52.230000,49.430000,52.200000,52.200000,368515,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-03-27,52.200000,52.960000,49.070000,49.410000,49.410000,326081,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-03-28,49.660000,51.020000,48.705000,50.380000,50.380000,294933,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-03-29,50.680000,51.890000,49.490000,50.990000,50.990000,284269,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-04-02,50.720000,51.100000,48.710000,49.380000,49.380000,472061,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-04-03,49.880000,51.200000,49.240000,50.740000,50.740000,334840,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-04-04,49.660000,52.610000,49.550000,52.280000,52.280000,301609,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-04-05,52.730000,53.190000,50.560000,50.860000,50.860000,226124,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-04-06,50.330000,51.310000,48.040000,48.540000,48.540000,351300,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-04-09,49.090000,51.360000,48.470000,50.710000,50.710000,358009,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-04-10,51.400000,52.980000,51.020000,52.670000,52.670000,605558,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-04-11,52.270000,53.540000,51.915000,52.940000,52.940000,219275,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-04-12,53.400000,55.000000,53.155000,54.940000,54.940000,245246,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-04-13,55.000000,55.000000,52.850000,53.120000,53.120000,251786,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-04-16,53.510000,54.285000,52.435000,53.820000,53.820000,336731,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-04-17,54.570000,57.920000,53.860000,54.680000,54.680000,923647,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-04-18,56.890000,56.930000,54.490000,54.910000,54.910000,835144,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-04-19,54.890000,55.360000,53.670000,53.870000,53.870000,464588,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-04-20,53.680000,55.350000,53.670000,54.260000,54.260000,561427,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-04-23,54.280000,54.640000,53.040000,53.740000,53.740000,401326,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-04-24,53.750000,54.330000,52.240000,52.610000,52.610000,319724,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-04-25,52.640000,53.110000,51.310000,51.490000,51.490000,305328,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-04-26,51.960000,52.380000,50.610000,51.220000,51.220000,320561,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-04-27,51.460000,52.455000,50.620000,51.950000,51.950000,245986,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-04-30,52.170000,52.780000,50.810000,50.840000,50.840000,222837,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-05-01,50.800000,52.499900,49.860000,52.410000,52.410000,359130,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-05-02,52.010000,54.010000,52.010000,53.350000,53.350000,262166,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-05-03,53.470000,54.340000,52.170000,52.660000,52.660000,356747,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-05-04,52.490000,55.090000,52.170000,54.500000,54.500000,311934,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-05-07,54.960000,58.290000,54.805000,57.960000,57.960000,672421,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-05-08,57.690000,59.200000,56.010000,57.800000,57.800000,688079,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-05-09,58.080000,59.660000,57.170000,59.400000,59.400000,434469,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-05-10,59.360000,60.790000,57.960000,59.760000,59.760000,541520,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-05-11,60.540000,64.420000,60.540000,64.120000,64.120000,586665,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-05-14,63.980000,65.320000,62.520000,64.360000,64.360000,775684,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-05-15,63.620000,63.980000,62.140000,62.690000,62.690000,476180,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-05-16,62.680000,65.000000,60.210000,63.940000,63.940000,1013382,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-05-17,64.730000,65.000000,62.650000,64.180000,64.180000,530550,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-05-18,64.470000,66.000000,64.300000,65.930000,65.930000,372466,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-05-21,65.760000,66.400000,64.350000,64.790000,64.790000,775161,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-05-22,64.850000,65.570000,64.020000,64.180000,64.180000,362800,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-05-23,63.750000,65.560000,63.750000,65.300000,65.300000,423236,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-05-24,65.400000,66.730000,64.310000,64.500000,64.500000,419810,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-05-25,64.610000,67.660000,64.000000,67.310000,67.310000,432593,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-05-29,66.580000,69.220000,66.450000,69.150000,69.150000,590244,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-05-30,69.290000,72.650000,69.212700,72.310000,72.310000,1175360,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-05-31,72.440000,73.630000,70.350000,73.200000,73.200000,653127,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-06-01,73.680000,74.940000,72.745000,73.730000,73.730000,539203,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-06-04,73.790000,74.240000,70.900000,73.800000,73.800000,504127,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-06-05,73.980000,74.780000,72.770000,73.070000,73.070000,506596,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-06-06,73.560000,77.620000,73.060000,77.580000,77.580000,642489,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-06-07,77.870000,80.990000,77.480000,80.240000,80.240000,1002350,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-06-08,78.800000,79.600000,76.810000,79.350000,79.350000,654449,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-06-11,79.280000,80.315000,77.820000,79.810000,79.810000,416514,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-06-12,79.800000,80.860000,77.940000,78.330000,78.330000,501433,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-06-13,77.980000,78.280000,76.000000,78.090000,78.090000,528669,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-06-14,78.570000,82.000000,76.690000,81.560000,81.560000,653196,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-06-15,81.330000,84.230000,79.610000,82.720000,82.720000,1768030,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-06-18,82.410000,82.550000,78.150000,79.020000,79.020000,455507,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-06-19,78.430000,80.950000,77.700000,80.690000,80.690000,538612,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-06-20,81.490000,86.100000,80.040000,85.310000,85.310000,485781,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-06-21,82.770000,84.210000,79.960000,82.350000,82.350000,672905,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-06-22,83.100000,84.550000,81.010000,84.260000,84.260000,984164,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-06-25,83.470000,84.242900,77.460000,79.540000,79.540000,472726,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-06-26,79.610000,82.210000,78.760000,81.810000,81.810000,359420,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-06-27,81.820000,81.820000,75.583600,75.860000,75.860000,458511,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-06-28,76.230000,77.300000,73.750000,76.140000,76.140000,522047,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-06-29,77.990000,77.990000,75.760000,76.870000,76.870000,507647,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-07-02,75.440000,78.390000,75.280000,78.310000,78.310000,343260,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-07-03,78.820000,80.499000,77.400000,78.200000,78.200000,212543,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-07-05,78.980000,79.890000,77.390000,77.990000,77.990000,268051,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-07-06,77.960000,83.460000,77.960000,82.460000,82.460000,478452,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-07-09,82.390000,83.060000,80.120000,82.900000,82.900000,634407,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-07-10,83.320000,83.969000,82.270000,83.130000,83.130000,385058,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-07-11,81.750000,84.000000,81.460000,83.660000,83.660000,358576,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-07-12,84.420000,84.430000,83.070000,84.070000,84.070000,376268,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-07-13,83.730000,85.000000,82.457500,84.560000,84.560000,421859,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-07-16,84.210000,84.970000,83.000000,84.350000,84.350000,396142,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-07-17,84.480000,87.330000,81.431000,85.220000,85.220000,572002,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-07-18,84.160000,85.270000,83.310000,84.680000,84.680000,381242,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-07-19,84.680000,85.220000,82.202000,83.900000,83.900000,523252,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-07-20,83.700000,85.499200,82.780000,82.900000,82.900000,719089,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-07-23,82.580000,83.130000,81.440000,81.580000,81.580000,260897,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-07-24,82.540000,82.750000,77.620000,79.230000,79.230000,434241,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-07-25,79.230000,81.500000,78.850000,81.350000,81.350000,514224,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-07-26,81.520000,82.030000,78.580000,80.320000,80.320000,453706,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-07-27,80.260000,80.375000,76.470000,77.730000,77.730000,342008,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-07-30,77.460000,79.090000,76.210000,77.550000,77.550000,308295,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-07-31,77.800000,82.030000,77.510000,79.110000,79.110000,485984,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-08-01,78.650000,80.217100,77.910000,79.340000,79.340000,288983,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-08-02,78.870000,79.940000,77.530000,79.580000,79.580000,438706,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-08-03,82.210000,82.730000,70.930000,71.805000,71.805000,1197299,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-08-06,72.270000,75.809500,69.730000,75.450000,75.450000,627517,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-08-07,76.110000,77.580000,76.090400,77.380000,77.380000,308733,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-08-08,77.210000,77.960000,76.200000,77.590000,77.590000,434161,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-08-09,77.500000,78.310000,76.405000,76.680000,76.680000,314983,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-08-10,75.780000,77.110000,75.070000,76.200000,76.200000,248210,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-08-13,76.340000,77.200000,75.260000,76.490000,76.490000,304205,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-08-14,76.990000,77.990000,75.950000,76.490000,76.490000,278582,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-08-15,76.120000,77.760000,74.920000,76.140000,76.140000,237136,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-08-16,76.450000,78.230000,74.950000,77.920000,77.920000,380826,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-08-17,77.730000,78.170000,76.430000,78.100000,78.100000,246260,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-08-20,79.040000,79.094000,76.300000,77.360000,77.360000,220349,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-08-21,77.800000,79.350000,76.990000,78.900000,78.900000,559665,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-08-22,79.280000,82.530000,78.875000,81.630000,81.630000,460266,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-08-23,81.410000,81.455000,75.410300,75.520000,75.520000,589758,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-08-24,75.880000,76.490000,74.750000,75.970000,75.970000,358127,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-08-27,76.420000,79.215000,76.320000,78.660000,78.660000,457686,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-08-28,78.600000,79.485000,76.475100,78.650000,78.650000,211489,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-08-29,80.510000,86.300000,80.510000,83.900000,83.900000,1038505,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-08-30,83.110000,86.650000,83.110000,86.440000,86.440000,331985,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-08-31,85.000000,85.990000,84.015000,84.730000,84.730000,309614,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-09-04,84.430000,84.750000,80.660000,83.670000,83.670000,521622,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-09-05,83.500000,87.950000,82.440000,87.650000,87.650000,720053,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-09-06,87.300000,88.410000,83.530000,84.400000,84.400000,451136,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-09-07,84.170000,86.620000,83.570000,84.760000,84.760000,384891,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-09-10,85.010000,86.650000,83.550000,84.490000,84.490000,327750,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-09-11,84.610000,86.000000,82.880000,84.700000,84.700000,233593,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-09-12,84.470000,86.190000,81.610000,83.780000,83.780000,742639,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-09-13,84.390000,85.400000,83.390000,84.690000,84.690000,175639,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-09-14,84.700000,87.220000,84.220000,86.800000,86.800000,352860,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-09-17,87.000000,88.000000,82.140000,82.470000,82.470000,327542,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-09-18,82.880000,85.450000,82.590000,85.010000,85.010000,248398,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-09-19,84.490000,87.000000,84.330000,85.880000,85.880000,301379,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-09-20,86.690000,88.179900,84.456000,86.290000,86.290000,447474,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-09-21,86.070000,86.540000,84.260000,84.870000,84.870000,561061,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-09-24,85.300000,88.710000,84.700000,88.640000,88.640000,409960,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-09-25,89.110000,90.980000,87.210000,90.150000,90.150000,503749,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-09-26,90.330000,90.790000,85.510000,85.720000,85.720000,551827,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-09-27,84.100000,84.312800,78.550000,79.820000,79.820000,685232,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-09-28,79.260000,80.076900,75.050000,76.340000,76.340000,1036696,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-10-01,76.730000,77.590000,75.950000,76.420000,76.420000,471776,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-10-02,76.740000,77.080000,73.650000,76.610000,76.610000,735431,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-10-03,76.620000,77.780000,74.250000,77.070000,77.070000,475680,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-10-04,76.650000,77.550000,75.330000,77.300000,77.300000,664025,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-10-05,77.110000,78.512500,70.000000,74.170000,74.170000,741410,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-10-08,73.380000,75.640000,72.673800,74.730000,74.730000,518581,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-10-09,74.850000,75.720000,71.080000,71.120000,71.120000,662224,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-10-10,70.760000,70.900000,67.820000,67.890000,67.890000,751019,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-10-11,67.040000,68.890000,65.770000,66.040000,66.040000,594237,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-10-12,67.860000,67.910800,63.381500,64.740000,64.740000,725459,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-10-15,64.440000,64.480000,60.580000,61.790000,61.790000,921080,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-10-16,62.150000,66.660000,61.090000,66.160000,66.160000,690195,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-10-17,66.010000,66.330000,64.270000,66.040000,66.040000,454704,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-10-18,66.120000,66.720000,63.070000,64.140000,64.140000,599077,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-10-19,64.330000,66.590000,62.670000,63.280000,63.280000,787033,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-10-22,63.180000,63.610000,60.690000,62.000000,62.000000,369057,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-10-23,60.600000,63.260000,58.580000,61.580000,61.580000,359601,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-10-24,61.560000,61.840000,54.390100,55.050000,55.050000,881848,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-10-25,55.190000,60.450000,55.190000,59.360000,59.360000,471654,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-10-26,51.140000,53.593100,48.140000,48.620000,48.620000,1570275,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-10-29,49.270000,50.490000,46.400000,47.550000,47.550000,510948,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-10-30,47.500000,49.960000,46.530000,49.430000,49.430000,696880,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-10-31,50.360000,50.940300,48.290000,48.450000,48.450000,624999,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-11-01,49.030000,54.320000,49.030000,54.170000,54.170000,1036061,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-11-02,54.780000,56.230000,53.020000,53.870000,53.870000,668811,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-11-05,53.940000,54.960000,51.769200,52.940000,52.940000,466278,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-11-06,54.260000,55.591800,50.510000,54.340000,54.340000,961389,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-11-07,55.340000,55.670000,52.830000,53.610000,53.610000,672122,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-11-08,55.670000,56.730000,53.260100,54.690000,54.690000,460887,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-11-09,54.110000,55.810000,51.630000,52.240000,52.240000,420730,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-11-12,51.740000,53.000000,48.890000,49.100000,49.100000,368427,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-11-13,49.710000,51.170000,48.400000,48.860000,48.860000,313637,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-11-14,49.620000,50.420000,46.740000,48.380000,48.380000,676933,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-11-15,47.860000,51.735000,47.860000,51.290000,51.290000,582200,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-11-16,50.790000,54.355000,50.790000,53.270000,53.270000,516369,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-11-19,52.610000,53.605000,49.260000,50.730000,50.730000,393669,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-11-20,49.380000,52.460000,48.680000,50.990000,50.990000,634268,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-11-21,51.800000,54.490000,51.410000,53.630000,53.630000,406910,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-11-23,52.700000,55.000000,52.700000,53.280000,53.280000,217198,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-11-26,54.350000,55.610000,53.563800,55.510000,55.510000,512525,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-11-27,54.700000,54.970000,52.070000,53.320000,53.320000,434980,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-11-28,53.820000,55.080000,52.770000,55.080000,55.080000,451991,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-11-29,54.550000,55.520000,53.500000,53.910000,53.910000,380915,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-11-30,53.410000,54.280000,52.140000,53.670000,53.670000,404802,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-12-03,55.210000,56.220000,53.360000,54.330000,54.330000,336907,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-12-04,54.090000,55.190000,50.260000,50.440000,50.440000,481114,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-12-06,50.000000,51.629900,48.932300,50.490000,50.490000,349126,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-12-07,49.690000,50.522500,46.245000,46.660000,46.660000,604745,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-12-10,46.500000,48.160000,45.600000,47.620000,47.620000,464479,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-12-11,48.440000,48.555000,45.630000,45.710000,45.710000,385434,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-12-12,46.570000,47.980000,45.920000,47.130000,47.130000,372260,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-12-13,47.380000,48.780000,46.260000,47.310000,47.310000,574979,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-12-14,46.560000,47.480000,45.010000,46.010000,46.010000,556635,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-12-17,45.880000,46.695000,43.940000,44.430000,44.430000,540969,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-12-18,44.920000,45.830000,42.960000,44.050000,44.050000,640274,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-12-19,44.060000,45.890000,42.360000,43.150000,43.150000,676239,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-12-20,42.780000,43.720000,40.790000,42.280000,42.280000,613203,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-12-21,42.490000,42.490000,38.130000,38.890000,38.890000,1325877,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-12-24,38.320000,40.310000,37.440000,39.210000,39.210000,298148,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-12-26,39.600000,41.800000,39.160000,41.740000,41.740000,553305,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-12-27,41.160000,42.420000,39.970000,42.020000,42.020000,558691,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-12-28,42.250000,42.980000,40.420000,41.870000,41.870000,253416,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2018-12-31,42.060000,43.565000,42.060000,43.480000,43.480000,369336,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-01-02,41.410000,43.020000,40.700000,41.720000,41.720000,645318,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-01-03,41.780000,42.610000,39.780000,39.870000,39.870000,577093,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-01-04,42.940000,44.180000,40.886800,43.000000,43.000000,1555043,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-01-07,43.230000,44.640000,42.310000,44.600000,44.600000,802279,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-01-08,44.480000,46.160000,43.800000,45.400000,45.400000,882773,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-01-09,45.940000,48.360000,45.210000,46.790000,46.790000,526969,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-01-10,46.310000,49.620000,45.230000,49.530000,49.530000,617618,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-01-11,49.410000,49.745000,48.250000,48.830000,48.830000,643199,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-01-14,48.290000,49.850000,47.940000,48.770000,48.770000,658210,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-01-15,48.880000,51.630000,48.390000,51.200000,51.200000,583709,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-01-16,51.420000,53.000000,50.600000,52.210000,52.210000,635783,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-01-17,51.550000,52.660000,50.505000,51.550000,51.550000,470004,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-01-18,51.760000,53.490000,51.200000,53.340000,53.340000,815894,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-01-22,52.920000,53.415000,50.780000,51.150000,51.150000,504936,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-01-23,51.910000,52.080000,48.860000,49.220000,49.220000,546755,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-01-24,49.050000,49.890000,48.620000,49.430000,49.430000,229462,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-01-25,49.860000,50.980000,49.125000,50.750000,50.750000,352423,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-01-28,49.540000,50.630000,48.360700,48.720000,48.720000,402744,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-01-29,48.640000,48.900000,47.910000,48.110000,48.110000,273437,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-01-30,48.200000,48.920000,46.510000,48.850000,48.850000,451398,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-01-31,48.710000,50.260000,48.336600,49.320000,49.320000,354063,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-02-01,49.430000,51.090000,49.010000,50.550000,50.550000,319209,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-02-04,50.590000,51.490000,49.800000,51.430000,51.430000,180784,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-02-05,49.950000,53.460000,49.670000,52.650000,52.650000,571343,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-02-06,52.750000,54.060000,52.190000,52.460000,52.460000,322994,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-02-07,52.080000,52.200000,49.920000,50.790000,50.790000,409790,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-02-08,50.600000,52.350000,50.600000,52.350000,52.350000,463595,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-02-11,52.360000,54.050000,51.950000,53.070000,53.070000,736630,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-02-12,53.130000,55.550000,52.470000,55.340000,55.340000,521230,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-02-13,55.800000,56.617600,54.540000,54.770000,54.770000,322136,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-02-14,54.500000,55.770000,54.500000,55.460000,55.460000,896500,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-02-15,55.620000,56.870000,55.270000,56.650000,56.650000,466454,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-02-19,56.710000,57.830000,56.210000,56.810000,56.810000,537607,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-02-20,59.940000,63.240000,56.340000,60.530000,60.530000,1064319,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-02-21,60.780000,60.780000,56.200000,58.260000,58.260000,927922,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-02-22,58.340000,60.130000,57.010000,59.820000,59.820000,420569,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-02-25,61.500000,65.680000,61.500000,63.370000,63.370000,742812,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-02-26,61.010000,62.650000,59.230000,61.510000,61.510000,1338809,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-02-27,61.500000,64.610000,60.255000,63.640000,63.640000,2886137,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-02-28,63.650000,64.640000,62.390000,64.140000,64.140000,862960,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-03-01,64.860000,67.990000,63.810000,67.550000,67.550000,1374983,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-03-04,68.000000,68.500000,64.000000,66.040000,66.040000,693631,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-03-05,65.520000,67.495000,64.491700,65.880000,65.880000,526661,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-03-06,65.710000,65.820000,62.372400,62.940000,62.940000,486539,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-03-07,63.140000,64.075000,61.310000,63.020000,63.020000,762954,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-03-08,62.190000,63.310000,61.450000,62.780000,62.780000,448233,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-03-11,62.900000,65.050000,62.900000,64.980000,64.980000,599696,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-03-12,65.250000,66.700000,63.710000,66.350000,66.350000,526300,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-03-13,66.880000,68.030000,65.820000,67.940000,67.940000,488415,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-03-14,67.950000,68.880000,65.710000,65.800000,65.800000,717704,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-03-15,66.280000,68.730000,65.990000,68.270000,68.270000,1153771,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-03-18,68.220000,70.350000,67.050000,68.360000,68.360000,781295,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-03-19,68.500000,69.250000,67.210000,68.430000,68.430000,419463,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-03-20,68.670000,69.925000,67.050000,68.050000,68.050000,633443,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-03-21,67.590000,70.017500,67.590000,69.040000,69.040000,466247,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-03-22,68.420000,68.880000,64.560000,64.650000,64.650000,650650,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-03-25,64.550000,66.600000,63.799900,65.730000,65.730000,716299,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-03-26,66.490000,68.560000,65.790000,68.470000,68.470000,484923,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-03-27,70.300000,71.630000,65.610000,67.310000,67.310000,817888,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-03-28,67.600000,68.500000,66.570000,68.340000,68.340000,325953,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-03-29,69.120000,69.650000,67.880000,69.360000,69.360000,731904,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-04-01,70.060000,71.300000,69.560000,70.000000,70.000000,551582,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-04-02,69.950000,73.190000,67.510000,72.630000,72.630000,407419,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-04-03,73.380000,74.450000,71.800000,73.210000,73.210000,494883,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-04-04,73.050000,73.670000,70.860000,71.230000,71.230000,409061,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-04-05,71.470000,74.500000,71.470000,74.360000,74.360000,406698,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-04-08,74.020000,74.380000,72.740000,73.360000,73.360000,367478,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-04-09,73.020000,73.930000,71.010000,72.010000,72.010000,455193,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-04-10,72.290000,74.110000,71.350000,73.130000,73.130000,403515,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-04-11,73.190000,74.000000,71.090000,71.480000,71.480000,519203,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-04-12,72.180000,73.740000,71.500000,72.840000,72.840000,498915,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-04-15,72.740000,73.980000,71.740000,72.260000,72.260000,376893,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-04-16,72.840000,73.000000,68.000000,68.320000,68.320000,747637,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-04-17,68.800000,68.800000,62.690000,64.710000,64.710000,987816,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-04-18,64.740000,66.139200,61.960000,64.430000,64.430000,1142855,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-04-22,64.250000,66.060000,63.350000,65.360000,65.360000,576945,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-04-23,64.750000,68.680000,64.750000,67.790000,67.790000,501630,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-04-24,68.140000,68.920000,66.650000,67.730000,67.730000,329515,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-04-25,67.610000,68.910000,67.010000,68.630000,68.630000,351805,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-04-26,68.250000,68.810000,67.370000,68.350000,68.350000,531399,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-04-29,68.300000,68.525000,67.000000,67.470000,67.470000,335639,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-04-30,67.650000,67.960000,65.250000,66.000000,66.000000,525068,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-05-01,66.100000,66.495000,63.960000,64.160000,64.160000,384259,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-05-02,64.050000,66.500000,63.795000,65.130000,65.130000,408939,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-05-03,65.620000,68.052500,64.600000,67.990000,67.990000,503618,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-05-06,65.900000,67.490000,65.445000,67.250000,67.250000,478589,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-05-07,64.900000,66.270000,61.030000,62.570000,62.570000,756639,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-05-08,62.230000,64.950000,61.351000,63.460000,63.460000,451728,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-05-09,62.490000,63.185000,60.330000,62.450000,62.450000,526067,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-05-10,62.040000,64.130000,61.650000,64.110000,64.110000,763245,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-05-13,62.120000,63.370000,60.290000,60.620000,60.620000,637440,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-05-14,61.170000,63.690000,60.710600,62.950000,62.950000,432733,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-05-15,62.220000,63.590000,62.140000,62.860000,62.860000,498473,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-05-16,63.120000,64.390000,63.120000,63.460000,63.460000,354412,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-05-17,62.480000,63.270000,61.270000,61.430000,61.430000,455892,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-05-20,60.980000,60.980000,58.420000,58.540000,58.540000,519293,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-05-21,59.070000,59.700000,58.310000,59.500000,59.500000,411714,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-05-22,59.130000,60.270000,57.660000,58.570000,58.570000,221434,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-05-23,57.640000,58.655000,55.900000,56.630000,56.630000,333217,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-05-24,57.030000,58.655000,56.800000,57.180000,57.180000,301290,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-05-28,57.250000,58.530000,56.685000,57.220000,57.220000,359313,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-05-29,56.570000,57.070000,55.460000,55.920000,55.920000,448283,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-05-30,55.760000,57.290000,55.590000,57.050000,57.050000,372958,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-05-31,55.790000,56.985000,54.820000,54.930000,54.930000,327859,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-06-03,54.960000,56.790000,54.410000,56.140000,56.140000,358848,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-06-04,57.230000,59.160000,55.520000,58.990000,58.990000,352494,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-06-05,59.310000,59.350000,57.370000,57.540000,57.540000,319526,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-06-06,57.390000,58.030000,55.490000,57.450000,57.450000,653876,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-06-07,58.030000,60.520000,57.370000,59.940000,59.940000,338177,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-06-10,60.510000,61.760000,60.470000,60.510000,60.510000,363660,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-06-11,61.250000,61.950000,58.200000,58.740000,58.740000,405963,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-06-12,58.800000,59.430000,57.510000,58.340000,58.340000,281902,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-06-13,58.830000,58.830000,56.920000,58.170000,58.170000,383495,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-06-14,58.050000,59.050000,56.940000,57.160000,57.160000,380842,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-06-17,57.680000,60.970000,57.670000,60.900000,60.900000,421474,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-06-18,61.910000,63.210000,60.800000,62.300000,62.300000,507845,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-06-19,62.100000,63.350000,61.530000,63.270000,63.270000,264098,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-06-20,64.360000,65.630000,62.940000,63.480000,63.480000,312311,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-06-21,63.010000,63.605000,61.420000,62.600000,62.600000,636499,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-06-24,62.550000,62.550000,60.060000,60.240000,60.240000,385342,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-06-25,60.680000,61.480000,59.210000,59.520000,59.520000,290581,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-06-26,59.890000,61.200000,59.500000,59.770000,59.770000,360857,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-06-27,60.100000,62.100000,59.450000,62.060000,62.060000,318523,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-06-28,62.200000,63.710000,61.830000,63.500000,63.500000,941169,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-07-01,64.980000,65.000000,61.820000,62.830000,62.830000,404229,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-07-02,62.950000,63.040000,61.850000,62.670000,62.670000,287042,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-07-03,62.760000,63.200000,62.040000,62.600000,62.600000,192393,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-07-05,62.170000,62.630000,59.280000,59.510000,59.510000,440944,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-07-08,58.660000,59.180000,55.840000,56.360000,56.360000,585034,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-07-09,56.130000,57.430000,55.530000,57.390000,57.390000,331678,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-07-10,57.830000,59.480000,56.760000,59.350000,59.350000,630452,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-07-11,59.750000,60.130000,56.700000,58.680000,58.680000,384126,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-07-12,58.620000,58.890000,57.640000,58.550000,58.550000,326855,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-07-15,58.800000,59.180000,58.270000,58.620000,58.620000,247597,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-07-16,58.560000,59.790000,58.010000,59.170000,59.170000,316550,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-07-17,59.000000,60.200000,58.510000,59.430000,59.430000,321058,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-07-18,59.060000,62.500000,59.060000,62.460000,62.460000,369471,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-07-19,62.580000,63.430000,61.850000,62.100000,62.100000,628248,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-07-22,62.680000,64.020000,61.740000,63.110000,63.110000,385937,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-07-23,63.540000,63.540000,60.080000,60.320000,60.320000,577873,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-07-24,60.230000,61.765000,58.820000,61.460000,61.460000,603363,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-07-25,61.460000,61.460000,60.030000,60.130000,60.130000,429834,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-07-26,60.250000,62.420000,60.020000,62.250000,62.250000,327708,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-07-29,62.220000,62.580000,60.140000,60.940000,60.940000,345664,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-07-30,60.180000,61.500000,59.710000,61.360000,61.360000,514694,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-07-31,61.740000,63.400000,60.030000,60.260000,60.260000,487806,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-08-01,60.790000,62.980000,60.250000,60.430000,60.430000,558149,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-08-02,58.070000,60.635000,55.400000,55.660000,55.660000,569189,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-08-05,54.590000,54.890000,52.790000,54.260000,54.260000,443978,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-08-06,54.980000,58.150000,54.800000,58.100000,58.100000,411114,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-08-07,57.000000,59.460000,56.650000,59.110000,59.110000,372597,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-08-08,59.730000,62.000000,58.890000,61.640000,61.640000,462085,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-08-09,60.860000,61.700000,60.020000,61.000000,61.000000,284427,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-08-12,60.490000,61.550000,59.380000,61.500000,61.500000,513767,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-08-13,60.890000,63.682000,60.490000,61.160000,61.160000,345570,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-08-14,59.570000,61.635000,58.700000,59.690000,59.690000,766057,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-08-15,59.770000,60.426000,56.710000,56.870000,56.870000,327459,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-08-16,57.560000,58.790000,57.526700,58.650000,58.650000,291895,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-08-19,59.990000,60.055000,58.580000,59.380000,59.380000,293458,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-08-20,59.010000,59.540000,57.510000,57.940000,57.940000,224083,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-08-21,58.860000,59.200000,57.770000,58.740000,58.740000,222292,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-08-22,59.080000,59.340000,56.520000,57.020000,57.020000,328320,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-08-23,56.570000,57.540000,55.020000,55.350000,55.350000,450304,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-08-26,55.960000,56.253300,53.760000,54.280000,54.280000,280560,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-08-27,54.870000,55.490000,50.430000,50.560000,50.560000,426725,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-08-28,50.320000,53.370000,49.800000,53.050000,53.050000,312006,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-08-29,53.720000,54.650000,53.450000,54.620000,54.620000,216024,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-08-30,54.960000,55.290000,53.418100,54.470000,54.470000,311266,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-09-03,54.020000,54.800000,51.090000,51.290000,51.290000,327168,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-09-04,52.300000,52.660000,44.740000,45.060000,45.060000,1768362,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-09-05,45.460000,48.550000,45.280000,46.540000,46.540000,879169,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-09-06,46.480000,46.700300,44.360000,44.760000,44.760000,720441,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-09-09,44.750000,44.750000,41.510000,42.650000,42.650000,997243,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-09-10,42.200000,43.890000,41.520000,43.130000,43.130000,1248245,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-09-11,43.330000,45.700000,42.690000,45.010000,45.010000,1998788,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-09-12,43.480000,45.860000,42.682000,44.690000,44.690000,826294,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-09-13,44.950000,45.470000,43.700000,44.100000,44.100000,940237,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-09-16,43.710000,45.710000,43.460000,44.760000,44.760000,486270,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-09-17,44.230000,45.570000,43.978900,44.220000,44.220000,449371,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-09-18,44.200000,44.809500,42.770000,43.540000,43.540000,471187,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-09-19,43.700000,44.420000,42.910000,43.370000,43.370000,576275,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-09-20,43.200000,44.600000,42.170000,42.570000,42.570000,1607829,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-09-23,42.060000,44.390000,42.060000,44.160000,44.160000,577261,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-09-24,44.460000,44.460000,41.420000,42.800000,42.800000,513119,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-09-25,42.880000,43.620000,42.261600,43.270000,43.270000,455254,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-09-26,43.270000,43.315000,42.023400,42.520000,42.520000,783254,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-09-27,42.440000,43.660000,41.350000,42.500000,42.500000,963941,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-09-30,42.810000,43.939900,42.300000,42.780000,42.780000,544150,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-10-01,42.520000,43.620000,41.840000,42.500000,42.500000,822939,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-10-02,42.270000,43.200000,41.350000,42.220000,42.220000,984678,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-10-03,42.300000,43.730000,41.690000,43.540000,43.540000,366664,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-10-04,43.700000,44.700000,43.220000,44.520000,44.520000,440506,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-10-07,44.400000,45.340000,44.190000,44.820000,44.820000,415480,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-10-08,44.100000,44.890000,43.210000,43.260000,43.260000,615415,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-10-09,43.930000,44.141000,41.870000,41.960000,41.960000,308163,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-10-10,42.070000,42.950000,41.520000,41.750000,41.750000,344379,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-10-11,42.340000,43.210000,41.970000,42.760000,42.760000,427170,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-10-14,42.750000,43.940000,41.380000,41.660000,41.660000,355840,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-10-15,41.650000,43.200000,41.650000,42.760000,42.760000,555683,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-10-16,42.600000,44.260000,42.600000,43.690000,43.690000,324379,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-10-17,43.750000,44.600000,43.350000,43.890000,43.890000,309672,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-10-18,43.800000,44.310000,42.130000,42.710000,42.710000,1091845,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-10-21,43.310000,44.135000,41.760000,41.990000,41.990000,473828,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-10-22,42.460000,42.580000,41.060000,41.480000,41.480000,366890,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-10-23,41.320000,41.810000,41.035000,41.170000,41.170000,354976,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-10-24,41.460000,41.485000,39.950000,40.270000,40.270000,300334,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-10-25,39.810000,41.420000,39.760000,40.940000,40.940000,424569,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-10-28,41.230000,42.360000,41.050000,42.070000,42.070000,351628,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-10-29,42.210000,42.210000,38.950000,39.490000,39.490000,608136,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-10-30,39.470000,40.750000,38.830000,40.300000,40.300000,298804,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-10-31,40.300000,40.920000,39.525000,40.140000,40.140000,288796,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-11-01,39.550000,41.080000,39.550000,40.790000,40.790000,440579,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-11-04,41.240000,41.580000,40.620000,40.760000,40.760000,331019,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-11-05,40.540000,40.815000,39.210000,39.860000,39.860000,511774,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-11-06,39.310000,40.120000,37.050100,37.520000,37.520000,888306,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-11-07,37.850000,39.000000,37.450000,37.500000,37.500000,863215,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-11-08,36.880000,39.490000,36.730000,38.900000,38.900000,481795,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-11-11,38.780000,38.835500,37.330000,37.500000,37.500000,341176,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-11-12,37.220000,38.500000,37.000000,37.080000,37.080000,391168,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-11-13,36.580000,38.020000,36.130000,37.280000,37.280000,401818,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-11-14,36.800000,37.210000,36.300000,36.780000,36.780000,532383,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-11-15,37.180000,37.380000,36.020000,36.080000,36.080000,506283,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-11-18,36.060000,36.810000,35.410000,36.720000,36.720000,780620,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-11-19,36.460000,37.750000,36.450000,37.500000,37.500000,522591,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-11-20,37.320000,39.110000,37.190000,38.570000,38.570000,658841,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-11-21,38.690000,39.205000,37.900000,38.430000,38.430000,511174,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-11-22,38.600000,39.500000,38.230000,38.690000,38.690000,338292,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-11-25,39.000000,39.385000,38.170000,38.910000,38.910000,738603,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-11-26,38.780000,39.740000,38.150000,38.850000,38.850000,541220,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-11-27,39.320000,39.550000,38.780000,39.295000,39.295000,884383,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-11-29,39.400000,40.230400,39.260000,39.650000,39.650000,340101,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-12-02,39.700000,40.060000,38.500000,39.140000,39.140000,627815,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-12-03,39.880000,42.000000,39.600000,41.560000,41.560000,1217655,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-12-04,41.840000,42.910000,41.080000,42.630000,42.630000,776400,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-12-05,42.570000,43.510000,42.190000,42.790000,42.790000,558040,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-12-06,43.070000,43.630000,42.500000,43.000000,43.000000,397967,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-12-09,43.280000,43.700000,41.335000,41.530000,41.530000,572542,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-12-10,41.360000,42.540000,41.020000,42.500000,42.500000,380024,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-12-11,42.550000,43.010000,40.780000,40.970000,40.970000,358077,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-12-12,40.920000,42.875000,40.920000,42.720000,42.720000,434167,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-12-13,42.590000,43.810000,42.190000,42.730000,42.730000,393662,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-12-16,43.240000,43.520000,42.530000,43.060000,43.060000,406026,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-12-17,43.380000,43.790000,42.410000,43.730000,43.730000,347448,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-12-18,44.780000,46.060000,44.020000,45.720000,45.720000,808593,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-12-19,45.850000,46.000000,42.910000,43.560000,43.560000,637971,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-12-20,43.600000,43.860000,41.720400,43.460000,43.460000,796318,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-12-23,43.550000,45.070000,43.060000,45.040000,45.040000,443417,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-12-24,45.020000,46.000000,44.850000,45.830000,45.830000,184127,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-12-26,45.920000,46.034400,45.070000,45.250000,45.250000,234589,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-12-27,45.510000,45.600000,43.280000,43.410000,43.410000,445364,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-12-30,43.510000,43.695000,42.390000,42.690000,42.690000,370940,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2019-12-31,42.470000,43.462400,42.090000,42.710000,42.710000,366647,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-01-02,43.180000,43.430000,41.430000,43.110000,43.110000,450684,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-01-03,42.230000,43.830000,42.173600,43.040000,43.040000,334409,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-01-06,42.640000,44.130000,42.040000,44.070000,44.070000,365145,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-01-07,43.860000,44.740000,43.325000,44.650000,44.650000,245542,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-01-08,44.760000,45.400000,44.215000,45.130000,45.130000,305973,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-01-09,45.490000,45.820000,43.450000,43.730000,43.730000,620344,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-01-10,48.910000,58.540000,48.840000,53.960000,53.960000,3273985,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-01-13,54.270000,57.620000,53.000000,57.520000,57.520000,1372635,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-01-14,57.430000,61.800000,56.380000,61.360000,61.360000,1289345,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-01-15,60.930000,63.920000,60.160000,60.990000,60.990000,645012,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-01-16,61.600000,61.955000,58.570000,60.880000,60.880000,427775,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-01-17,61.750000,61.750000,59.420000,59.960000,59.960000,736586,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-01-21,60.000000,60.765000,58.780000,59.020000,59.020000,470956,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-01-22,59.340000,60.500000,58.150000,58.460000,58.460000,885858,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-01-23,58.430000,58.500000,56.880000,57.225000,57.225000,473144,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-01-24,57.830000,58.359900,55.840000,56.970000,56.970000,454891,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-01-27,55.560000,57.000000,55.110000,56.360000,56.360000,402999,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-01-28,56.890000,58.000000,54.350000,55.020000,55.020000,341356,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-01-29,54.870000,55.490000,54.220000,54.810000,54.810000,195198,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-01-30,54.250000,54.670000,52.260000,53.230000,53.230000,414493,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-01-31,52.910000,53.640000,51.020000,52.550000,52.550000,331233,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-02-03,52.660000,54.010000,52.060000,53.860000,53.860000,377535,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-02-04,54.510000,58.560000,54.420000,58.300000,58.300000,464144,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-02-05,58.810000,60.590000,58.260000,59.310000,59.310000,509486,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-02-06,59.520000,60.500000,59.270000,59.960000,59.960000,359806,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-02-07,59.660000,60.230000,59.187500,60.060000,60.060000,375117,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-02-10,60.120000,61.430000,60.000000,61.320000,61.320000,264084,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-02-11,61.920000,62.950000,59.290000,61.600000,61.600000,499806,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-02-12,62.240000,62.959100,60.875000,62.880000,62.880000,318778,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-02-13,62.460000,63.310000,62.030000,62.900000,62.900000,400479,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-02-14,63.050000,64.240000,60.400000,61.130000,61.130000,510971,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-02-18,60.610000,61.620000,59.600000,61.100000,61.100000,486742,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-02-19,61.220000,62.105000,60.500000,61.550000,61.550000,326935,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-02-20,61.460000,61.960000,59.060000,60.850000,60.850000,524766,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-02-21,60.840000,61.380000,58.650000,59.390000,59.390000,405023,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-02-24,57.320000,57.770000,55.475000,57.020000,57.020000,427597,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-02-25,57.490000,58.270000,54.655000,54.800000,54.800000,357666,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-02-26,55.390000,57.400000,54.990000,55.710000,55.710000,302135,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-02-27,54.200000,55.940000,52.660000,53.140000,53.140000,552429,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-02-28,51.090000,56.220000,50.723200,56.080000,56.080000,686057,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-03-02,56.630000,57.200000,54.070100,57.070000,57.070000,474294,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-03-03,57.280000,57.750000,53.360000,54.250000,54.250000,331931,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-03-04,51.320000,56.150000,51.020000,56.100000,56.100000,602279,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-03-05,54.850000,55.875000,53.320000,54.020000,54.020000,338602,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-03-06,52.060000,53.620000,48.890000,50.320000,50.320000,616378,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-03-09,46.150000,49.550000,45.300000,45.650000,45.650000,552889,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-03-10,47.240000,49.225000,44.980000,49.180000,49.180000,463005,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-03-11,47.650000,48.870000,44.400000,45.350000,45.350000,500804,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-03-12,41.630000,43.630000,37.180000,41.340000,41.340000,932539,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-03-13,43.450000,44.680000,36.800000,43.340000,43.340000,761843,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-03-16,32.560000,39.600000,32.560000,33.800000,33.800000,976244,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-03-17,34.670000,37.870000,31.990000,37.500000,37.500000,1102645,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-03-18,35.280000,39.040000,32.870100,34.940000,34.940000,831424,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-03-19,34.940000,38.960000,34.270000,38.240000,38.240000,914051,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-03-20,38.720000,40.900000,36.387300,37.370000,37.370000,775329,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-03-23,38.030000,41.740000,36.235000,38.130000,38.130000,591594,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-03-24,40.040000,41.875000,38.270000,41.490000,41.490000,833588,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-03-25,41.530000,43.100000,40.520000,42.460000,42.460000,578425,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-03-26,42.910000,45.400000,41.950000,44.500000,44.500000,546074,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-03-27,42.500000,43.370000,40.760000,42.360000,42.360000,478046,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-03-30,42.840000,44.740000,41.510000,44.320000,44.320000,442201,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-03-31,44.080000,44.880000,42.570000,44.430000,44.430000,483848,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-04-01,43.240000,48.570000,42.320000,46.910000,46.910000,1104865,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-04-02,46.940000,50.020000,46.460000,50.020000,50.020000,697875,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-04-03,50.000000,50.000000,47.082500,48.300000,48.300000,408748,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-04-06,49.840000,51.890000,48.500000,51.460000,51.460000,609138,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-04-07,52.770000,53.900000,50.105300,50.710000,50.710000,657079,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-04-08,52.060000,53.570000,50.215000,53.020000,53.020000,379323,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-04-09,54.050000,55.560000,51.210000,52.500000,52.500000,536530,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-04-13,51.730000,54.190000,51.730000,53.230000,53.230000,412163,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-04-14,54.500000,57.880000,54.500000,57.590000,57.590000,564606,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-04-15,56.430000,57.800000,54.300000,56.110000,56.110000,896460,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-04-16,56.500000,57.800000,54.730000,56.660000,56.660000,413612,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-04-17,58.070000,58.850000,56.150000,58.570000,58.570000,525541,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-04-20,58.050000,64.605500,57.770000,63.100000,63.100000,953652,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-04-21,58.260000,62.970000,58.260000,62.120000,62.120000,635051,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-04-22,63.700000,65.300000,62.465000,64.530000,64.530000,686976,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-04-23,64.620000,67.272800,64.310000,64.570000,64.570000,497388,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-04-24,64.750000,66.670000,64.340000,66.230000,66.230000,505742,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-04-27,66.980000,70.493000,65.780000,68.970000,68.970000,652063,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-04-28,69.880000,69.880000,63.670000,63.700000,63.700000,540897,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-04-29,65.300000,65.854700,63.225000,63.640000,63.640000,524475,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-04-30,62.850000,64.655000,60.380000,60.430000,60.430000,496741,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-05-01,59.730000,60.780000,57.100000,58.650000,58.650000,475960,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-05-04,58.460000,64.800000,57.450000,64.720000,64.720000,597140,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-05-05,65.940000,66.310000,63.910000,64.680000,64.680000,367256,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-05-06,65.120000,67.530000,64.211400,66.260000,66.260000,395468,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-05-07,68.900000,68.900000,62.610000,63.120000,63.120000,694833,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-05-08,63.030000,65.930000,62.260000,63.840000,63.840000,411076,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-05-11,63.980000,67.620000,62.740000,67.360000,67.360000,707979,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-05-12,68.000000,69.990000,65.930000,66.290000,66.290000,506210,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-05-13,65.200000,67.410000,61.958500,64.080000,64.080000,447334,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-05-14,62.500000,65.490000,62.340000,64.730000,64.730000,460396,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-05-15,65.260000,71.310000,63.940000,71.290000,71.290000,632388,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-05-18,72.000000,76.000000,71.550000,72.590000,72.590000,945622,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-05-19,72.600000,73.850000,71.379000,71.610000,71.610000,617652,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-05-20,71.650000,72.580000,69.000000,70.630000,70.630000,458741,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-05-21,70.630000,71.760000,69.540000,70.490000,70.490000,349038,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-05-22,70.540000,74.080000,70.200000,73.810000,73.810000,482991,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-05-26,74.930000,75.760000,73.020000,73.590000,73.590000,863986,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-05-27,74.180000,74.180000,68.111000,71.110000,71.110000,558625,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-05-28,71.810000,72.670000,68.340000,68.590000,68.590000,357823,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-05-29,68.970000,69.520000,65.950000,68.460000,68.460000,420945,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-06-01,68.480000,70.730000,67.030000,69.600000,69.600000,359270,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-06-02,69.380000,75.200000,68.290000,75.090000,75.090000,628204,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-06-03,74.690000,74.980000,72.280000,72.500000,72.500000,496669,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-06-04,71.890000,74.025000,69.600000,69.900000,69.900000,369939,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-06-05,70.250000,71.540000,65.310000,69.920000,69.920000,436290,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-06-08,70.300000,71.710000,68.830000,70.670000,70.670000,316732,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-06-09,70.460000,72.970000,70.220000,71.850000,71.850000,345502,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-06-10,72.770000,73.770000,71.190000,71.310000,71.310000,271719,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-06-11,69.670000,69.670000,66.320000,66.460000,66.460000,511935,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-06-12,68.360000,69.170000,66.220000,68.060000,68.060000,370022,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-06-15,66.890000,69.650000,66.140000,69.210000,69.210000,316368,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-06-16,71.300000,72.060000,69.000000,70.800000,70.800000,287036,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-06-17,71.120000,72.380000,69.790000,71.490000,71.490000,570426,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-06-18,71.060000,73.920000,70.960000,72.480000,72.480000,527120,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-06-19,72.990000,78.220000,70.870000,78.220000,78.220000,1610751,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-06-22,77.870000,77.870000,74.254000,76.790000,76.790000,610879,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-06-23,77.770000,79.670000,77.170000,77.800000,77.800000,548399,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-06-24,77.230000,78.480000,73.090000,73.520000,73.520000,455277,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-06-25,73.400000,78.070000,73.071000,77.530000,77.530000,595129,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-06-26,77.180000,78.100000,75.270000,76.580000,76.580000,1186135,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-06-29,77.170000,77.170000,73.020000,73.660000,73.660000,375400,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-06-30,73.170000,78.740000,72.430000,78.220000,78.220000,1236800,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-07-01,79.640000,85.500000,78.650000,84.650000,84.650000,1295700,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-07-02,84.880000,86.110000,83.260000,86.040000,86.040000,665200,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-07-06,87.060000,90.980000,86.590000,86.750000,86.750000,714300,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-07-07,87.170000,90.760000,86.860000,87.880000,87.880000,445700,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-07-08,88.370000,91.770000,87.810000,90.000000,90.000000,394200,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-07-09,89.910000,90.420000,86.450000,87.950000,87.950000,317400,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-07-10,88.320000,88.850000,85.840000,86.260000,86.260000,259200,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-07-13,87.170000,87.800000,81.740000,81.950000,81.950000,475000,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-07-14,82.320000,84.330000,79.910000,84.290000,84.290000,365000,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-07-15,86.290000,87.720000,84.840000,85.410000,85.410000,326100,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-07-16,84.400000,85.200000,82.590000,84.990000,84.990000,386000,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-07-17,84.220000,87.090000,83.430000,85.880000,85.880000,713500,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-07-20,86.880000,90.190000,86.382000,87.910000,87.910000,322235,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-07-21,87.620000,88.880000,84.005000,84.300000,84.300000,256365,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-07-22,84.650000,86.135000,82.450000,82.950000,82.950000,273054,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-07-23,82.920000,83.640000,78.350000,78.930000,78.930000,358339,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-07-24,78.010000,78.520000,76.140000,77.770000,77.770000,387921,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-07-27,77.370000,81.640000,76.730400,81.420000,81.420000,385548,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-07-28,80.950000,80.950000,76.820000,76.840000,76.840000,376873,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-07-29,77.650000,78.230000,75.220000,76.250000,76.250000,339307,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-07-30,75.280000,78.690000,75.120000,77.600000,77.600000,333138,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-07-31,82.360000,84.500000,77.250000,78.160000,78.160000,557188,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-08-03,78.560000,83.910000,78.375000,83.540000,83.540000,431689,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-08-04,83.430000,84.370000,81.514100,84.170000,84.170000,358154,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-08-05,84.700000,85.350000,82.340000,83.460000,83.460000,276524,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-08-06,83.530000,84.810000,82.905000,84.560000,84.560000,224978,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-08-07,84.660000,87.810000,84.120000,84.840000,84.840000,289732,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-08-10,84.750000,85.870000,83.880000,85.150000,85.150000,275059,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-08-11,85.290000,86.150000,82.655000,82.860000,82.860000,320901,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-08-12,83.390000,84.615000,81.870000,83.810000,83.810000,315559,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-08-13,84.250000,86.980000,83.938500,85.890000,85.890000,256497,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-08-14,85.570000,86.060000,83.790000,85.110000,85.110000,202702,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-08-17,84.900000,90.920000,84.900000,87.560000,87.560000,314679,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-08-18,87.170000,88.670000,84.860000,87.900000,87.900000,278054,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-08-19,88.200000,89.700000,86.880000,87.940000,87.940000,309509,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-08-20,87.100000,88.700000,86.360000,87.960000,87.960000,130001,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-08-21,87.960000,88.470000,86.460000,87.560000,87.560000,266811,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-08-24,88.690000,89.420000,83.255000,84.530000,84.530000,256613,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-08-25,84.320000,87.500000,84.320000,87.050000,87.050000,226188,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-08-26,87.000000,87.980000,83.490000,83.580000,83.580000,285705,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-08-27,84.050000,84.550000,80.870000,83.990000,83.990000,296567,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-08-28,84.680000,86.209900,83.230000,85.690000,85.690000,186228,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-08-31,85.590000,87.466000,84.910000,85.060000,85.060000,350550,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-09-01,85.160000,85.160000,81.500000,82.300000,82.300000,347962,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-09-02,82.080000,82.600000,78.920000,80.860000,80.860000,378377,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-09-03,80.310000,80.690000,77.240000,78.090000,78.090000,411881,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-09-04,78.540000,79.370000,73.320000,75.810000,75.810000,441809,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-09-08,73.700000,75.890000,72.830000,72.980000,72.980000,351442,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-09-09,74.090000,76.640000,73.820000,76.330000,76.330000,395862,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-09-10,76.380000,79.250000,73.420000,74.270000,74.270000,508545,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-09-11,75.290000,76.790000,73.320000,73.830000,73.830000,281132,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-09-14,75.280000,78.360000,75.280000,77.240000,77.240000,545212,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-09-15,78.000000,82.480000,77.360000,81.230000,81.230000,478497,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-09-16,81.490000,83.650000,81.130000,82.400000,82.400000,440565,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-09-17,81.020000,82.690000,80.440000,82.420000,82.420000,340154,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-09-18,83.730000,84.800000,80.000000,82.870000,82.870000,701992,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-09-21,81.500000,83.840000,79.950000,80.450000,80.450000,381028,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-09-22,80.530000,82.860000,77.560000,82.810000,82.810000,341511,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-09-23,83.070000,85.825000,82.390000,82.740000,82.740000,334820,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-09-24,82.410000,82.910000,78.850000,80.010000,80.010000,214426,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-09-25,80.030000,82.250000,79.723100,82.070000,82.070000,257182,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-09-28,82.900000,83.210000,81.045000,82.500000,82.500000,188400,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-09-29,82.730000,85.729900,82.300000,85.100000,85.100000,297361,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-09-30,85.460000,86.710000,81.760000,82.190000,82.190000,245958,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-10-01,82.500000,85.720000,82.430000,85.710000,85.710000,394925,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-10-02,84.360000,87.750000,83.350000,84.400000,84.400000,386412,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-10-05,84.540000,89.670000,84.540000,89.250000,89.250000,359020,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-10-06,89.830000,91.570000,88.290000,88.890000,88.890000,330870,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-10-07,89.940000,94.880000,88.910000,94.200000,94.200000,374115,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-10-08,94.670000,96.580000,92.960000,94.430000,94.430000,472277,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-10-09,95.000000,96.500000,93.150000,94.450000,94.450000,232219,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-10-12,94.450000,96.480000,92.600000,95.500000,95.500000,294830,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-10-13,95.280000,98.050000,93.970000,97.400000,97.400000,283086,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-10-14,96.600000,99.250000,91.300000,92.690000,92.690000,325923,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-10-15,88.000000,94.560000,87.272600,93.770000,93.770000,325815,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-10-16,92.090000,95.900000,90.850000,91.970000,91.970000,487992,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-10-19,92.560000,93.070000,90.520000,91.150000,91.150000,282575,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-10-20,91.260000,92.220000,86.848100,90.000000,90.000000,301787,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-10-21,90.560000,91.270000,87.650000,89.130000,89.130000,197040,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-10-22,89.620000,92.630000,89.620000,91.900000,91.900000,272906,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-10-23,92.000000,94.610000,90.570000,93.060000,93.060000,248554,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-10-26,92.260000,94.800000,90.390000,91.250000,91.250000,299422,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-10-27,91.090000,99.790000,90.030000,97.440000,97.440000,745349,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-10-28,92.580000,100.000000,90.500000,95.000000,95.000000,615393,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-10-29,92.770000,97.800000,91.950000,95.000000,95.000000,1706637,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-10-30,94.840000,102.145000,93.840000,100.500000,100.500000,1256097,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-11-02,100.010000,101.540000,91.170000,95.530000,95.530000,1517982,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-11-03,95.950000,102.770000,95.081000,102.000000,102.000000,634651,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-11-04,103.380000,114.165000,102.900000,113.530000,113.530000,757831,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-11-05,113.170000,115.873300,112.360000,114.410000,114.410000,503255,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-11-06,114.410000,115.460000,111.220000,111.420000,111.420000,329701,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-11-09,115.700000,118.800000,111.080000,113.720000,113.720000,483924,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-11-10,113.870000,118.000000,111.250000,117.480000,117.480000,386932,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-11-11,118.920000,122.510000,117.660000,120.680000,120.680000,341488,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-11-12,117.620000,123.350000,111.690000,115.480000,115.480000,600078,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-11-13,116.880000,118.157500,115.510000,117.220000,117.220000,223135,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-11-16,118.150000,119.180000,115.950000,118.670000,118.670000,291878,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-11-17,118.240000,119.740000,114.440100,119.370000,119.370000,216949,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-11-18,120.000000,120.000000,113.900000,114.050000,114.050000,308587,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-11-19,113.090000,116.980000,111.785000,112.820000,112.820000,305356,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-11-20,112.290000,114.780000,110.205000,114.370000,114.370000,266546,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-11-23,115.270000,117.000000,113.570000,114.690000,114.690000,192685,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-11-24,115.560000,119.490000,114.000000,118.880000,118.880000,391534,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-11-25,119.650000,124.360000,118.259700,119.830000,119.830000,377403,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-11-27,120.500000,123.070000,120.060000,122.420000,122.420000,169256,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-11-30,122.560000,124.130000,117.520000,118.540000,118.540000,529435,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-12-01,120.200000,121.230000,116.300000,117.380000,117.380000,320664,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-12-02,116.910000,119.130000,115.150000,117.980000,117.980000,258849,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-12-03,117.950000,124.550000,117.950000,124.140000,124.140000,404090,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-12-04,124.540000,129.910000,124.165000,128.530000,128.530000,409413,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-12-07,127.190000,130.060000,127.190000,129.930000,129.930000,456863,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-12-08,129.870000,138.520000,129.370000,137.680000,137.680000,425435,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-12-09,137.730000,142.300000,128.030000,128.870000,128.870000,474412,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-12-10,127.770000,135.530000,127.770000,134.190000,134.190000,418844,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-12-11,133.650000,146.880000,132.690000,144.940000,144.940000,540884,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-12-14,145.800000,158.285000,145.800000,153.220000,153.220000,930119,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-12-15,154.770000,159.290000,154.010000,158.880000,158.880000,417363,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-12-16,160.000000,164.150000,158.450000,160.860000,160.860000,374819,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-12-17,162.030000,166.960000,161.530000,164.560000,164.560000,398917,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-12-18,163.640000,168.390000,162.825000,168.040000,168.040000,1329758,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-12-21,163.720000,168.030000,161.980000,167.400000,167.400000,457152,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-12-22,169.180000,175.580000,166.280000,173.000000,173.000000,529934,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-12-23,174.280000,177.965000,168.043900,177.390000,177.390000,312979,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-12-24,179.090000,179.647000,168.757700,172.870000,172.870000,157293,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-12-28,175.110000,175.870000,169.880000,169.890000,169.890000,514305,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-12-29,168.750000,171.305000,141.960000,147.440000,147.440000,1310349,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-12-30,148.500000,150.495000,138.525000,144.370000,144.370000,1103509,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2020-12-31,144.990000,145.725000,137.831700,138.430000,138.430000,834193,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-01-04,138.540000,138.667200,134.810000,136.470000,136.470000,780022,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-01-05,137.310000,140.810000,133.190000,134.990000,134.990000,374225,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-01-06,133.730000,138.500000,131.840000,137.490000,137.490000,554474,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-01-07,138.050000,145.600000,138.040000,145.400000,145.400000,653223,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-01-08,145.450000,153.155000,145.410000,150.590000,150.590000,918481,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-01-11,150.830000,152.800000,140.400000,141.740000,141.740000,664621,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-01-12,141.470000,143.440000,136.305000,137.640000,137.640000,555037,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-01-13,137.500000,139.430000,133.850000,134.710000,134.710000,618472,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-01-14,134.540000,140.330000,134.230000,139.870000,139.870000,365992,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-01-15,139.000000,141.860000,136.690000,137.970000,137.970000,808528,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-01-19,140.600000,141.935000,136.220000,138.870000,138.870000,473471,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-01-20,138.650000,140.610000,134.480000,135.150000,135.150000,401873,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-01-21,136.620000,136.620000,131.190000,133.090000,133.090000,501155,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-01-22,131.740000,140.860000,131.740000,140.470000,140.470000,415339,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-01-25,140.790000,147.448700,138.673300,146.760000,146.760000,460337,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-01-26,147.670000,148.490000,138.930000,139.970000,139.970000,291326,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-01-27,135.880000,140.405000,130.219200,136.160000,136.160000,453997,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-01-28,138.990000,144.205100,137.010000,140.600000,140.600000,370953,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-01-29,139.810000,144.180000,136.300000,138.590000,138.590000,286131,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-02-01,140.360000,146.899900,139.580000,145.630000,145.630000,409111,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-02-02,148.480000,153.440000,145.650000,153.150000,153.150000,314358,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-02-03,153.750000,155.600000,145.370000,150.240000,150.240000,490061,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-02-04,151.380000,155.110000,149.270000,155.000000,155.000000,282187,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-02-05,157.300000,163.130000,155.370000,162.220000,162.220000,238009,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-02-08,164.410000,166.170000,158.020000,165.840000,165.840000,447813,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-02-09,166.560000,171.870000,164.830000,167.730000,167.730000,252611,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-02-10,169.030000,175.000000,160.800000,167.220000,167.220000,529693,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-02-11,170.530000,171.510000,159.640000,162.780000,162.780000,285982,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-02-12,155.760000,155.760000,145.800000,150.260000,150.260000,679319,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-02-16,150.340000,151.690000,144.060100,144.340000,144.340000,480627,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-02-17,143.380000,144.890000,139.280000,143.110000,143.110000,415125,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-02-18,141.600000,146.395000,140.575000,143.000000,143.000000,421633,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-02-19,143.840000,149.970000,143.840000,148.140000,148.140000,656931,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-02-22,146.270000,148.660000,143.830000,144.690000,144.690000,388343,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-02-23,141.890000,142.600000,135.575000,140.220000,140.220000,488292,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-02-24,140.000000,144.000000,137.530000,142.730000,142.730000,260985,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-02-25,142.550000,146.910000,136.180000,136.250000,136.250000,313098,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-02-26,138.060000,142.290000,134.530000,141.540000,141.540000,433681,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-03-01,142.640000,145.000000,139.870000,142.470000,142.470000,278606,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-03-02,138.160000,144.760000,138.160000,139.930000,139.930000,369167,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-03-03,129.830000,133.510000,125.275000,125.300000,125.300000,703211,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-03-04,125.300000,126.145000,116.440000,118.630000,118.630000,467468,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-03-05,120.840000,120.840000,110.660000,118.500000,118.500000,525045,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-03-08,118.600000,121.715000,113.530000,115.000000,115.000000,415761,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-03-09,119.560000,128.120000,119.560000,124.220000,124.220000,495783,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-03-10,127.630000,128.070000,119.510000,119.960000,119.960000,371881,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-03-11,123.780000,127.130000,119.810000,126.850000,126.850000,369778,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-03-12,124.550000,127.170000,123.000000,126.950000,126.950000,199490,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-03-15,125.640000,129.830000,123.890000,129.270000,129.270000,204164,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-03-16,131.140000,133.820000,125.000000,129.260000,129.260000,645442,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-03-17,127.260000,130.680000,124.860000,128.880000,128.880000,357540,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-03-18,126.780000,127.275000,119.130000,119.990000,119.990000,343796,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-03-19,119.450000,126.460000,117.180000,124.730000,124.730000,947064,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-03-22,125.360000,126.270000,122.050000,123.570000,123.570000,259093,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-03-23,121.030000,123.559900,116.760000,117.000000,117.000000,377975,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-03-24,119.420000,119.480000,110.730000,110.950000,110.950000,401672,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-03-25,110.140000,111.700000,102.900100,110.820000,110.820000,794644,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-03-26,111.360000,111.780000,103.910000,108.640000,108.640000,437713,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-03-29,108.250000,109.680000,104.660000,106.900000,106.900000,325791,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-03-30,107.100000,115.140000,105.010000,112.060000,112.060000,546988,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-03-31,112.550000,116.690000,110.820000,113.860000,113.860000,764436,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-04-01,115.550000,115.930000,111.470000,113.200000,113.200000,410162,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-04-05,114.820000,120.000000,111.660000,113.420000,113.420000,245125,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-04-06,113.120000,115.400000,108.600000,109.190000,109.190000,703657,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-04-07,108.740000,111.110000,104.720000,105.270000,105.270000,283616,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-04-08,107.230000,108.210000,103.080000,106.550000,106.550000,488297,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-04-09,105.910000,105.910000,101.150000,103.480000,103.480000,325403,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-04-12,103.760000,103.830000,99.610000,100.530000,100.530000,556049,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-04-13,102.470000,107.140000,101.440000,106.590000,106.590000,456572,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-04-14,107.740000,111.675000,107.240000,107.970000,107.970000,251681,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-04-15,108.880000,110.620000,107.330000,109.580000,109.580000,208910,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-04-16,110.730000,110.730000,107.660000,108.720000,108.720000,378406,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-04-19,106.670000,109.070000,103.860000,105.390000,105.390000,327589,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-04-20,104.280000,108.565000,102.115000,104.990000,104.990000,382388,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-04-21,104.630000,109.370000,103.630000,109.140000,109.140000,219285,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-04-22,109.570000,111.910000,106.330000,108.870000,108.870000,371629,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-04-23,110.100000,110.840000,106.980000,109.870000,109.870000,275742,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-04-26,110.630000,115.000000,109.560000,114.870000,114.870000,259093,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-04-27,115.070000,116.145000,112.110000,113.360000,113.360000,585761,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-04-28,112.240000,116.455000,110.590000,114.850000,114.850000,247710,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-04-29,116.050000,116.840000,111.560000,113.510000,113.510000,223427,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-04-30,111.920000,115.395000,110.630000,111.640000,111.640000,304929,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-05-03,111.960000,113.630000,106.140000,106.510000,106.510000,323383,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-05-04,105.680000,107.060000,100.925000,101.850000,101.850000,890366,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-05-05,101.860000,109.700000,101.510000,106.010000,106.010000,392048,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-05-06,115.430000,119.540000,110.860000,115.710000,115.710000,864598,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-05-07,113.670000,117.500000,112.045000,114.530000,114.530000,664271,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-05-10,112.420000,112.420000,108.070000,109.250000,109.250000,742723,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-05-11,104.060000,110.720000,103.150000,108.480000,108.480000,660603,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-05-12,106.220000,108.970000,104.690000,106.400000,106.400000,446185,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-05-13,108.720000,109.550000,102.290000,106.710000,106.710000,306365,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-05-14,108.190000,111.850000,106.760000,110.880000,110.880000,281323,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-05-17,110.600000,113.020000,108.500000,110.290000,110.290000,373361,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-05-18,110.120000,115.250000,108.920000,111.430000,111.430000,628715,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-05-19,109.680000,112.780000,107.710000,108.620000,108.620000,232244,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-05-20,109.330000,114.980000,108.940000,111.840000,111.840000,316407,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-05-21,113.410000,113.410000,107.210000,107.340000,107.340000,438809,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-05-24,108.240000,109.188800,105.360000,105.590000,105.590000,348438,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-05-25,105.910000,107.785000,103.310000,103.830000,103.830000,527270,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-05-26,105.100000,105.100000,102.110000,102.900000,102.900000,362272,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-05-27,103.690000,104.520000,101.410000,103.540000,103.540000,615526,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-05-28,104.220000,105.990000,100.950000,101.710000,101.710000,250104,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-06-01,101.650000,101.650000,99.060000,99.830000,99.830000,372453,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-06-02,100.220000,101.510000,96.520000,97.700000,97.700000,367256,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-06-03,96.510000,98.900000,94.120000,94.370000,94.370000,284584,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-06-04,94.320000,95.020000,92.045000,92.190000,92.190000,444255,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-06-07,92.090000,98.820000,91.930000,95.490000,95.490000,1042754,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-06-08,96.920000,97.616800,92.595000,93.450000,93.450000,319697,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-06-09,94.130000,95.930000,92.880000,94.380000,94.380000,383406,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-06-10,94.570000,102.980000,94.570000,99.360000,99.360000,1179298,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-06-11,100.210000,102.210000,98.760000,101.710000,101.710000,676597,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-06-14,103.850000,105.506000,101.440000,102.880000,102.880000,593348,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-06-15,102.300000,102.340000,98.480000,100.040000,100.040000,501018,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-06-16,99.520000,99.930000,95.760000,97.780000,97.780000,336756,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-06-17,96.970000,97.200000,93.610000,95.980000,95.980000,653179,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-06-18,94.520000,95.420000,92.910000,94.920000,94.920000,813514,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-06-21,94.960000,96.770000,93.560000,95.490000,95.490000,993471,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-06-22,94.950000,96.230000,92.205000,94.770000,94.770000,519637,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-06-23,94.630000,95.790000,92.620000,93.720000,93.720000,489854,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-06-24,94.540000,95.530000,92.290000,93.200000,93.200000,622738,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-06-25,94.040000,94.850000,92.580000,93.830000,93.830000,8056823,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-06-28,95.112000,99.940000,94.595700,96.400000,96.400000,658182,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-06-29,102.430000,102.430000,95.285000,96.290000,96.290000,567695,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-06-30,96.400000,97.790000,94.335000,95.350000,95.350000,550981,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-07-01,95.100000,95.870000,92.430000,94.110000,94.110000,663733,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-07-02,94.270000,94.850000,92.310000,94.210000,94.210000,313630,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-07-06,94.080700,95.390000,91.000000,91.420000,91.420000,723294,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-07-07,91.530000,92.440000,87.660000,89.630000,89.630000,419503,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-07-08,88.140000,93.320000,88.120000,92.900000,92.900000,578182,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-07-09,93.220000,93.280000,90.935000,91.340000,91.340000,343656,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-07-12,92.110000,92.787000,90.210000,91.380000,91.380000,465821,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-07-13,91.230000,93.290000,87.500000,87.570000,87.570000,409026,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-07-14,87.960000,88.898900,84.330000,84.740000,84.740000,456721,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-07-15,84.320000,85.520000,82.610000,84.750000,84.750000,364112,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-07-16,85.500000,85.735000,82.935000,85.330000,85.330000,896682,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-07-19,84.030000,86.650000,83.460000,84.260000,84.260000,338703,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-07-20,84.250000,86.600000,83.760000,86.550000,86.550000,516821,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-07-21,86.430000,86.430000,84.120000,84.910000,84.910000,303946,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-07-22,84.090000,84.690000,82.500000,83.550000,83.550000,312440,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-07-23,83.910000,83.910000,81.610000,82.720000,82.720000,322521,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-07-26,82.410000,82.460000,79.240000,79.360000,79.360000,345337,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-07-27,78.910000,79.700000,76.795000,79.290000,79.290000,237414,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-07-28,79.550000,81.880000,79.540000,81.300000,81.300000,334664,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-07-29,81.120000,83.230000,80.240000,80.350000,80.350000,295175,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-07-30,79.980000,81.770000,79.760000,79.830000,79.830000,372030,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-08-02,79.960000,82.040000,79.850000,80.840000,80.840000,507830,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-08-03,80.665000,83.780000,76.775000,83.770000,83.770000,766770,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-08-04,83.850000,88.230000,81.020000,85.450000,85.450000,727816,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-08-05,85.400000,90.670000,84.110000,90.310000,90.310000,561460,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-08-06,90.000000,90.465000,87.680000,88.500000,88.500000,618228,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-08-09,88.820000,90.520000,87.880000,89.990000,89.990000,314025,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-08-10,91.020000,92.330000,89.445000,91.830000,91.830000,484101,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-08-11,91.680000,93.070000,90.530000,92.740000,92.740000,524054,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-08-12,92.550000,93.170000,89.480000,92.710000,92.710000,769747,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-08-13,93.270000,93.950000,91.160000,92.740000,92.740000,412239,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-08-16,92.560000,92.710000,87.860000,88.000000,88.000000,521356,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-08-17,86.280000,89.240000,85.020000,88.700000,88.700000,514979,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-08-18,88.840000,91.980000,81.670000,81.960000,81.960000,438065,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-08-19,79.790000,81.470000,77.530000,77.920000,77.920000,405589,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-08-20,78.030000,80.510000,77.360000,80.160000,80.160000,276092,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-08-23,81.360000,84.790000,80.680100,84.650000,84.650000,362778,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-08-24,85.080000,88.230000,83.790000,87.380000,87.380000,228054,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-08-25,87.380000,90.420000,86.880000,90.140000,90.140000,240429,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-08-26,90.220000,92.645000,89.250000,89.980000,89.980000,322519,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-08-27,90.180000,95.070000,90.180000,93.950000,93.950000,366396,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-08-30,94.620000,96.770000,93.685000,95.790000,95.790000,454805,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-08-31,96.040000,97.970000,95.940000,96.290000,96.290000,429964,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-09-01,96.700000,100.170000,96.250000,99.650000,99.650000,399137,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-09-02,99.820000,101.630000,99.656100,101.470000,101.470000,320084,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-09-03,101.130000,103.330000,100.780000,102.400000,102.400000,325649,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-09-07,102.340000,104.380000,99.420000,101.980000,101.980000,337188,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-09-08,100.650000,102.570000,100.000000,102.300000,102.300000,262751,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-09-09,101.710000,104.310000,101.060000,101.240000,101.240000,366658,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-09-10,101.470000,102.690000,99.980000,101.690000,101.690000,322721,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-09-13,102.810000,103.140000,100.165000,100.470000,100.470000,516867,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-09-14,100.220000,100.650000,94.850000,95.150000,95.150000,498759,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-09-15,95.200000,99.470000,94.370000,97.000000,97.000000,383191,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-09-16,96.490000,97.160000,94.520000,96.230000,96.230000,363396,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-09-17,97.000000,98.310000,95.540000,98.270000,98.270000,467346,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-09-20,95.850000,99.790000,95.710000,96.440000,96.440000,400088,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-09-21,96.930000,98.220000,95.970000,96.060000,96.060000,302266,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-09-22,96.200000,97.240000,94.820000,96.490000,96.490000,335133,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-09-23,96.630000,98.425000,96.380000,97.500000,97.500000,403015,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-09-24,96.670000,97.280000,94.970000,95.110000,95.110000,232860,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-09-27,95.040000,95.365000,87.630000,88.660000,88.660000,717210,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-09-28,87.490000,89.710000,86.680000,87.000000,87.000000,492872,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-09-29,87.460000,88.510000,86.030000,86.120000,86.120000,504915,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-09-30,87.420000,91.100000,86.930000,90.190000,90.190000,290393,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-10-01,89.720000,89.720000,86.455000,87.800000,87.800000,399145,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-10-04,86.810000,86.810000,84.540000,84.980000,84.980000,180833,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-10-05,85.080000,87.210000,84.920000,87.120000,87.120000,194424,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-10-06,86.670000,87.950000,85.410000,86.490000,86.490000,366272,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-10-07,85.945000,88.410000,85.230000,85.450000,85.450000,327201,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-10-08,85.420000,85.420000,81.450000,81.640000,81.640000,350073,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-10-11,81.470000,82.760000,80.380000,80.990000,80.990000,520463,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-10-12,81.690000,84.370000,81.050000,82.790000,82.790000,531282,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-10-13,82.790000,84.040000,80.870000,81.080000,81.080000,332007,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-10-14,81.810000,82.205000,80.710000,81.000000,81.000000,521785,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-10-15,81.140000,82.660000,79.680000,80.000000,80.000000,359439,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-10-18,78.880000,79.090000,77.760000,78.020000,78.020000,354663,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-10-19,78.150000,79.710000,77.790000,78.040000,78.040000,221744,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-10-20,78.440000,79.180000,76.800000,76.960000,76.960000,847760,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-10-21,77.450000,80.010000,77.370000,78.400000,78.400000,527165,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-10-22,78.620000,78.620000,75.830000,78.220000,78.220000,361849,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-10-25,78.080000,80.520000,77.945000,79.690000,79.690000,406805,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-10-26,80.650000,81.650000,79.000000,80.500000,80.500000,476482,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-10-27,80.120000,81.960000,79.345000,81.650000,81.650000,296390,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-10-28,81.590000,84.970000,81.110000,84.770000,84.770000,417503,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-10-29,84.620000,85.870000,82.720000,83.920000,83.920000,367224,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-11-01,83.580000,86.200000,82.880000,85.980000,85.980000,262982,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-11-02,86.160000,86.970000,83.905000,84.830000,84.830000,289174,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-11-03,87.110000,89.560000,82.750000,86.000000,86.000000,779751,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-11-04,85.750000,87.045000,84.360000,85.740000,85.740000,549418,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-11-05,85.310000,86.920000,83.095000,83.340000,83.340000,277483,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-11-08,83.360000,86.080000,82.290000,82.600000,82.600000,536515,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-11-09,82.990000,83.090000,80.770000,80.920000,80.920000,264241,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-11-10,80.220000,82.322900,79.100000,80.140000,80.140000,290740,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-11-11,80.370000,82.030000,79.600000,81.860000,81.860000,268592,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-11-12,81.680000,82.065000,79.710000,80.530000,80.530000,185762,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-11-15,80.850000,81.925000,78.890000,80.540000,80.540000,256273,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-11-16,80.410000,81.230000,78.860000,79.100000,79.100000,261641,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-11-17,78.980000,79.790000,76.908600,77.490000,77.490000,337525,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-11-18,77.610000,78.900000,75.710000,77.390000,77.390000,570544,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-11-19,77.510000,79.450000,77.145000,79.320000,79.320000,306234,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-11-22,79.950000,80.400000,76.570000,77.620000,77.620000,390895,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-11-23,77.420000,78.310000,74.110000,77.000000,77.000000,480089,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-11-24,76.510000,78.390000,75.135000,77.580000,77.580000,326956,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-11-26,76.740000,77.543800,75.325000,76.490000,76.490000,226696,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-11-29,78.645000,78.690000,73.430000,73.710000,73.710000,364881,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-11-30,73.660000,76.150000,72.890000,75.230000,75.230000,525763,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-12-01,75.420000,77.760000,75.200000,76.160000,76.160000,1367233,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-12-02,75.690000,79.640000,75.590000,79.120000,79.120000,495756,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-12-03,79.250000,79.680000,75.770000,76.010000,76.010000,822707,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-12-06,75.300000,79.120000,75.300000,78.890000,78.890000,343456,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-12-07,79.820000,85.395000,79.820000,84.440000,84.440000,703103,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-12-08,84.660000,85.030000,80.990000,81.010000,81.010000,300948,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-12-09,80.520000,81.310000,78.260000,78.490000,78.490000,407905,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-12-10,78.820000,80.220000,77.300000,77.900000,77.900000,297972,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-12-13,77.900000,80.320000,77.310000,79.630000,79.630000,411158,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-12-14,78.590000,82.800000,78.300000,81.750000,81.750000,298311,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-12-15,81.750000,84.040000,79.595000,83.050000,83.050000,388692,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-12-16,83.010000,84.060000,79.000000,79.860000,79.860000,336371,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-12-17,78.790000,86.440000,77.870000,84.850000,84.850000,1016538,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-12-20,84.480000,88.050000,83.580000,87.500000,87.500000,671754,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-12-21,87.600000,88.220000,85.750000,87.860000,87.860000,376210,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-12-22,87.510000,87.510000,84.500000,85.670000,85.670000,399653,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-12-23,85.690000,86.130000,84.485000,84.740000,84.740000,295929,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-12-27,84.090000,85.640000,83.590000,83.680000,83.680000,303662,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-12-28,83.240000,86.390000,80.869000,83.050000,83.050000,197046,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-12-29,82.810000,82.810000,80.660000,82.720000,82.720000,221767,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-12-30,82.830000,86.180000,82.830000,84.250000,84.250000,231708,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2021-12-31,83.990000,85.870000,83.640000,84.090000,84.090000,221890,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-01-03,84.080000,85.680000,81.880000,84.400000,84.400000,237115,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-01-04,84.090000,84.880000,80.240000,83.190000,83.190000,310003,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-01-05,83.920000,88.120000,82.735000,83.560000,83.560000,689292,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-01-06,82.690000,84.400000,79.370000,79.390000,79.390000,397641,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-01-07,79.850000,79.850000,73.660000,73.790000,73.790000,636838,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-01-10,71.860000,73.320000,69.090000,73.100000,73.100000,781414,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-01-11,73.340000,74.080000,71.220000,72.760000,72.760000,358815,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-01-12,72.630000,73.820000,69.830000,71.210000,71.210000,354316,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-01-13,71.550000,71.880000,69.345000,69.890000,69.890000,434568,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-01-14,69.340000,72.095000,68.200000,72.050000,72.050000,416468,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-01-18,70.730000,70.840000,67.630000,67.670000,67.670000,349859,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-01-19,67.930000,69.540000,66.335000,66.750000,66.750000,286524,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-01-20,67.910000,71.022500,67.910000,68.970000,68.970000,397135,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-01-21,68.420000,70.508600,67.020000,67.170000,67.170000,350297,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-01-24,65.720000,68.190000,63.375000,67.960000,67.960000,463197,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-01-25,67.010000,70.830000,65.970000,69.070000,69.070000,336200,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-01-26,69.750000,72.790000,67.610000,68.110000,68.110000,345435,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-01-27,68.490000,69.360000,64.280000,64.330000,64.330000,413398,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-01-28,64.530000,66.190000,62.370000,66.000000,66.000000,414416,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-01-31,66.300000,70.140000,66.010000,69.930000,69.930000,514832,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-02-01,70.160000,72.040000,68.890000,72.040000,72.040000,407603,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-02-02,71.950000,73.000000,69.435000,69.910000,69.910000,315252,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-02-03,68.390000,71.030000,67.470000,67.610000,67.610000,359098,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-02-04,67.370000,69.910000,66.850100,68.620000,68.620000,373561,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-02-07,68.620000,71.120000,67.920000,69.790000,69.790000,247219,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-02-08,69.130000,70.020000,67.750000,69.070000,69.070000,337075,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-02-09,70.160000,74.750000,68.900000,74.750000,74.750000,382993,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-02-10,74.120000,75.980000,70.150000,71.400000,71.400000,533733,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-02-11,78.570000,79.720000,72.310000,72.910000,72.910000,989793,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-02-14,71.940000,73.100000,70.670000,71.250000,71.250000,753478,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-02-15,72.720000,74.760000,71.255000,73.550000,73.550000,744854,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-02-16,72.280000,74.030000,70.560000,71.170000,71.170000,509340,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-02-17,70.550000,70.730000,66.404400,67.230000,67.230000,509752,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-02-18,67.610000,68.000000,65.730000,66.710000,66.710000,277916,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-02-22,66.100000,68.010000,66.100000,66.920000,66.920000,162219,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-02-23,67.540000,68.276500,64.650000,64.790000,64.790000,296231,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-02-24,63.330000,68.060000,63.235000,67.820000,67.820000,296266,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-02-25,68.150000,68.150000,65.915000,67.450000,67.450000,355319,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-02-28,67.070000,68.730000,65.840000,67.320000,67.320000,725725,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-03-01,67.040000,68.820000,66.500000,67.370000,67.370000,253778,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-03-02,66.620000,68.700000,66.620000,67.420000,67.420000,437174,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-03-03,64.550000,65.990000,62.130000,64.080000,64.080000,668515,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-03-04,63.070000,64.880000,62.400000,62.780000,62.780000,252521,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-03-07,62.860000,64.670000,62.765000,63.000000,63.000000,257684,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-03-08,63.090000,68.010000,62.330000,66.850000,66.850000,319849,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-03-09,67.740000,69.740000,67.380000,67.660000,67.660000,461411,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-03-10,67.050000,67.740000,66.120000,67.520000,67.520000,243720,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-03-11,67.700000,68.820000,65.290000,65.410000,65.410000,282078,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-03-14,65.260000,68.510000,61.205000,62.200000,62.200000,464307,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-03-15,62.820000,63.690000,61.960000,63.690000,63.690000,203605,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-03-16,66.510000,67.990000,65.010000,67.760000,67.760000,489968,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-03-17,67.800000,69.240000,67.480000,68.860000,68.860000,518211,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-03-18,68.280000,69.920000,67.970000,69.780000,69.780000,665176,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-03-21,68.890000,70.000000,66.190000,68.780000,68.780000,269593,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-03-22,68.580000,71.500000,68.580000,70.780000,70.780000,416711,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-03-23,70.540000,70.770000,67.140000,68.770000,68.770000,421819,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-03-24,69.510000,69.740000,68.110000,69.120000,69.120000,207731,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-03-25,69.290000,69.350000,67.690000,68.870000,68.870000,239070,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-03-28,69.100000,69.810000,66.360000,67.970000,67.970000,228009,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-03-29,68.670000,71.560000,68.670000,71.490000,71.490000,543105,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-03-30,71.290000,73.620000,70.045000,71.360000,71.360000,403016,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-03-31,71.440000,73.300000,71.110000,72.620000,72.620000,425105,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-04-01,72.640000,77.490000,72.470000,77.370000,77.370000,618572,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-04-04,78.020000,79.945000,77.180000,78.150000,78.150000,529107,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-04-05,78.380000,81.000000,76.785000,80.700000,80.700000,621020,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-04-06,79.520000,84.024800,79.140000,82.850000,82.850000,574615,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-04-07,82.270000,84.000000,81.750000,82.160000,82.160000,501112,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-04-08,82.050000,83.549400,80.860000,81.890000,81.890000,462860,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-04-11,80.850000,80.860000,77.287800,79.270000,79.270000,562046,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-04-12,80.230000,82.250000,79.780000,80.840000,80.840000,453844,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-04-13,80.890000,84.690000,80.500000,84.580000,84.580000,441533,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-04-14,84.710000,85.530000,83.385000,85.400000,85.400000,611638,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-04-18,84.550000,84.560000,78.190000,78.440000,78.440000,812582,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-04-19,78.250000,80.395000,77.800000,78.100000,78.100000,398078,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-04-20,78.670000,79.570000,76.210000,78.720000,78.720000,325074,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-04-21,79.390000,79.980000,74.860000,75.220000,75.220000,402469,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-04-22,74.840000,77.080000,73.780000,75.060000,75.060000,266187,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-04-25,75.190000,76.390000,74.230000,75.660000,75.660000,253031,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-04-26,74.950000,76.080000,70.740000,70.740000,70.740000,357442,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-04-27,70.740000,71.525000,69.285000,70.980000,70.980000,427430,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-04-28,72.120000,72.240000,67.345000,71.170000,71.170000,673351,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-04-29,70.990000,72.370000,70.380000,70.690000,70.690000,416952,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-05-02,70.330000,72.350000,69.210000,72.290000,72.290000,364500,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-05-03,72.150000,73.390000,71.000000,71.470000,71.470000,179251,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-05-04,71.800000,71.800000,67.970000,70.930000,70.930000,360405,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-05-05,69.760000,70.660000,65.000000,66.430000,66.430000,405406,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-05-06,63.500000,66.980000,56.587500,57.540000,57.540000,966353,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-05-09,55.880000,56.700000,50.981000,51.800000,51.800000,723496,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-05-10,54.430000,57.050000,51.950000,53.560000,53.560000,565912,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-05-11,52.410000,54.710000,50.290000,50.880000,50.880000,524129,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-05-12,50.070000,52.050000,49.240000,50.420000,50.420000,1054945,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-05-13,51.010000,53.170000,51.010000,51.470000,51.470000,1269943,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-05-16,51.360000,55.829900,50.860000,55.260000,55.260000,781953,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-05-17,56.280000,56.840000,53.560000,54.350000,54.350000,521310,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-05-18,52.640000,54.160000,47.690000,47.700000,47.700000,946780,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-05-19,47.310000,48.340000,46.140000,47.000000,47.000000,919800,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-05-20,47.810000,49.130000,46.020000,48.550000,48.550000,1018863,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-05-23,48.900000,50.260000,47.100000,47.940000,47.940000,433461,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-05-24,47.430000,47.850000,45.520000,45.800000,45.800000,443770,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-05-25,45.570000,46.700000,45.200000,45.920000,45.920000,462996,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-05-26,46.100000,46.960000,45.580000,45.840000,45.840000,966222,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-05-27,45.850000,48.680000,45.300000,48.640000,48.640000,494529,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-05-31,48.420000,48.750000,45.940000,46.900000,46.900000,587585,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-06-01,47.270000,48.090000,45.410000,46.140000,46.140000,560947,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-06-02,46.040000,50.340000,45.700000,49.960000,49.960000,599229,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-06-03,49.550000,51.770000,49.080000,51.410000,51.410000,602641,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-06-06,52.030000,52.585000,48.830000,49.260000,49.260000,570287,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-06-07,48.920000,53.240000,48.795000,53.230000,53.230000,402301,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-06-08,52.800000,55.180000,52.470000,54.390000,54.390000,469273,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-06-09,53.510000,53.790000,50.950000,51.090000,51.090000,375194,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-06-10,50.220000,50.345000,48.970000,49.880000,49.880000,350709,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-06-13,48.090000,48.785000,46.305000,47.680000,47.680000,602273,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-06-14,48.100000,48.280000,46.520000,47.410000,47.410000,478719,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-06-15,47.590000,51.330000,47.140000,50.710000,50.710000,738107,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-06-16,49.430000,50.105000,48.120000,50.020000,50.020000,441638,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-06-17,50.160000,55.090000,50.160000,53.290000,53.290000,1418656,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-06-21,53.980000,56.540000,53.450000,55.570000,55.570000,672488,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-06-22,54.780000,58.000000,54.120000,56.120000,56.120000,390940,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-06-23,56.100000,60.090000,56.080000,59.990000,59.990000,396214,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-06-24,60.690000,60.690000,57.190000,60.570000,60.570000,653293,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-06-27,60.770000,61.705000,58.620000,61.180000,61.180000,491254,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-06-28,61.480000,61.950000,58.490000,58.730000,58.730000,369782,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-06-29,58.460000,60.280000,57.450000,60.240000,60.240000,306633,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-06-30,59.410000,60.240000,58.140000,59.660000,59.660000,656585,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-07-01,59.840000,63.280000,58.645000,62.650000,62.650000,455255,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-07-05,61.950000,64.605000,61.360000,63.800000,63.800000,553141,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-07-06,63.730000,66.060000,63.040000,63.380000,63.380000,636231,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-07-07,62.970000,64.770000,62.910000,63.830000,63.830000,552878,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-07-08,63.140000,66.340000,62.970000,66.140000,66.140000,447949,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-07-11,65.770000,67.370000,65.000000,65.870000,65.870000,661234,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-07-12,65.930000,66.210000,63.100000,65.860000,65.860000,477389,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-07-13,64.390000,68.680000,62.940000,65.830000,65.830000,341697,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-07-14,66.010000,67.160000,64.570000,64.570000,64.570000,504764,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-07-15,64.570000,66.740000,63.600000,64.750000,64.750000,562835,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-07-18,64.910000,66.290000,60.930000,61.020000,61.020000,505814,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-07-19,55.960000,55.960000,49.100000,52.890000,52.890000,4753977,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-07-20,52.370000,55.000000,52.061000,54.730000,54.730000,1203108,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-07-21,55.120000,55.290000,53.980000,54.220000,54.220000,818892,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-07-22,54.490000,54.870000,51.400000,51.490000,51.490000,792481,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-07-25,51.170000,52.005000,50.090000,50.930000,50.930000,557498,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-07-26,50.850000,51.240000,49.300000,50.160000,50.160000,932814,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-07-27,50.300000,50.950000,49.675000,50.810000,50.810000,646598,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-07-28,51.280000,52.930000,49.970000,51.880000,51.880000,502364,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-07-29,51.500000,54.640000,51.380000,53.280000,53.280000,862105,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-08-01,51.750000,52.425000,49.800000,50.630000,50.630000,849461,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-08-02,50.560000,52.140000,50.480000,51.280000,51.280000,406648,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-08-03,51.810000,55.275000,51.810000,53.600000,53.600000,364113,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-08-04,54.270000,55.970000,54.130000,55.770000,55.770000,462356,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-08-05,54.500000,56.420000,54.290000,55.600000,55.600000,677727,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-08-08,55.420000,56.130000,51.250000,52.630000,52.630000,845611,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-08-09,52.000000,52.350000,50.360000,51.370000,51.370000,622294,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-08-10,52.350000,52.580000,51.020000,52.160000,52.160000,578789,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-08-11,52.070000,52.820000,50.590000,51.250000,51.250000,744447,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-08-12,51.560000,52.360000,50.985000,51.570000,51.570000,595816,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-08-15,51.440000,51.700000,49.730000,51.200000,51.200000,1206020,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-08-16,50.980000,50.980000,49.000000,49.310000,49.310000,1028055,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-08-17,48.770000,49.300000,47.170000,47.250000,47.250000,759612,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-08-18,47.010000,48.670000,46.330000,48.670000,48.670000,1505278,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-08-19,48.610000,49.080000,47.560000,49.030000,49.030000,430394,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-08-22,48.530000,50.690000,47.930000,48.150000,48.150000,522709,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-08-23,48.380000,48.880000,47.340000,48.690000,48.690000,411070,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-08-24,48.880000,53.570000,48.880000,52.080000,52.080000,891691,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-08-25,52.280000,53.360000,51.105000,51.460000,51.460000,580120,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-08-26,51.600000,51.880000,49.325000,49.500000,49.500000,511200,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-08-29,48.670000,50.125000,48.670000,49.110000,49.110000,577012,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-08-30,49.960000,50.270000,48.323000,49.120000,49.120000,656673,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-08-31,49.700000,50.295000,47.070000,47.690000,47.690000,842594,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-09-01,47.690000,48.480000,46.760000,48.470000,48.470000,516807,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-09-02,49.220000,49.970000,47.520000,47.750000,47.750000,368499,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-09-06,47.650000,47.865000,46.590100,47.000000,47.000000,420074,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-09-07,46.960000,47.800000,46.260000,47.000000,47.000000,926886,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-09-08,46.830000,48.200000,46.800000,47.730000,47.730000,505420,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-09-09,47.940000,49.250000,47.420000,49.240000,49.240000,693686,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-09-12,49.470000,49.980000,48.370000,48.780000,48.780000,366389,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-09-13,47.630000,47.750000,45.550000,45.810000,45.810000,703098,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-09-14,45.920000,46.440000,44.755000,45.270000,45.270000,615374,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-09-15,45.100000,47.530000,45.100000,47.280000,47.280000,685958,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-09-16,46.780000,46.825000,45.500000,46.030000,46.030000,1055063,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-09-19,45.840000,46.470000,44.970000,45.790000,45.790000,502118,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-09-20,45.420000,46.410000,44.880000,45.310000,45.310000,344372,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-09-21,45.360000,45.940000,44.018000,44.080000,44.080000,454186,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-09-22,43.760000,43.910000,42.690000,43.140000,43.140000,419827,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-09-23,42.730000,43.245000,40.840000,41.500000,41.500000,555717,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-09-26,41.390000,42.300000,39.750000,39.960000,39.960000,586663,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-09-27,40.620000,42.070000,39.980000,40.290000,40.290000,657506,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-09-28,41.240000,41.640000,40.560000,41.270000,41.270000,732630,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-09-29,40.900000,41.070000,39.550000,40.550000,40.550000,519513,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-09-30,40.660000,43.000000,40.660000,41.410000,41.410000,902961,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-10-03,42.170000,42.280000,40.890000,41.930000,41.930000,805165,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-10-04,42.790000,43.380000,42.080000,42.660000,42.660000,899537,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-10-05,42.200000,42.390000,40.530000,40.540000,40.540000,814672,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-10-06,40.230000,40.640000,39.820000,39.940000,39.940000,1351715,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-10-07,39.150000,39.800000,37.625000,37.930000,37.930000,1030039,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-10-10,37.720000,38.505000,37.039600,37.190000,37.190000,1041157,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-10-11,37.060000,39.020000,36.860000,37.460000,37.460000,1249107,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-10-12,37.680000,38.790000,36.910000,38.470000,38.470000,589980,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-10-13,38.220000,40.130000,38.045000,39.650000,39.650000,941923,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-10-14,40.160000,40.720000,37.000000,37.060000,37.060000,953793,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-10-17,37.470000,38.530000,36.700000,38.300000,38.300000,726292,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-10-18,38.860000,40.400000,38.650000,39.450000,39.450000,706681,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-10-19,38.870000,39.330000,37.850000,37.980000,37.980000,917808,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-10-20,38.100000,39.055000,37.280000,37.810000,37.810000,663822,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-10-21,37.750000,38.720000,37.110000,38.490000,38.490000,1618873,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-10-24,38.520000,38.520000,36.670000,37.140000,37.140000,599252,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-10-25,37.480000,39.650000,37.480000,39.390000,39.390000,607404,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-10-26,39.350000,41.310000,39.105000,39.970000,39.970000,537625,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-10-27,40.410000,40.680000,39.010000,39.330000,39.330000,493400,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-10-28,39.330000,40.960000,38.580000,40.760000,40.760000,406222,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-10-31,40.410000,41.470000,40.360000,40.460000,40.460000,577013,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-11-01,40.950000,42.070000,40.280000,41.930000,41.930000,518630,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-11-02,42.300000,42.800000,40.530000,40.590000,40.590000,491725,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-11-03,40.690000,41.980000,36.670100,38.170000,38.170000,732111,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-11-04,38.710000,38.710000,35.070000,35.270000,35.270000,1020273,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-11-07,35.500000,36.365000,34.830700,35.070000,35.070000,631847,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-11-08,35.270000,36.590000,34.280000,34.740000,34.740000,570061,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-11-09,34.330000,34.510000,33.620000,33.720000,33.720000,809860,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-11-10,35.600000,37.600000,34.990000,37.580000,37.580000,1782921,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-11-11,36.720000,37.770000,35.380000,36.550000,36.550000,1113428,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-11-14,36.760000,37.661600,35.200000,35.250000,35.250000,838757,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-11-15,36.300000,36.810000,34.895000,35.460000,35.460000,769769,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-11-16,35.460000,35.810000,34.230000,35.220000,35.220000,717585,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-11-17,34.600000,35.180000,34.000000,35.120000,35.120000,612722,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-11-18,35.820000,36.290000,35.630000,35.990000,35.990000,878546,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-11-21,36.010000,36.150000,34.320000,34.370000,34.370000,832664,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-11-22,34.140000,34.825000,33.360000,34.650000,34.650000,667696,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-11-23,34.830000,35.860000,34.100000,34.590000,34.590000,597383,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-11-25,34.650000,36.840000,34.550000,35.720000,35.720000,532936,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-11-28,35.690000,36.330000,35.180000,35.400000,35.400000,675203,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-11-29,35.400000,36.140000,34.780000,35.670000,35.670000,572298,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-11-30,36.140000,36.800000,35.230100,36.300000,36.300000,1647199,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-12-01,36.570000,37.880000,36.385000,37.810000,37.810000,1556419,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-12-02,37.380000,40.220000,36.505000,40.170000,40.170000,1429903,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-12-05,40.050000,40.450000,39.230000,39.830000,39.830000,602644,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-12-06,39.570000,39.710000,38.510000,39.220000,39.220000,600353,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-12-07,39.070000,40.570000,38.955000,39.510000,39.510000,884292,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-12-08,39.830000,41.830000,39.040000,41.210000,41.210000,511037,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-12-09,41.010000,41.090000,40.202300,40.650000,40.650000,706385,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-12-12,40.920000,43.015000,40.130000,42.780000,42.780000,889812,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-12-13,43.540000,45.260000,43.170000,44.930000,44.930000,883108,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-12-14,44.930000,46.170000,44.315000,45.460000,45.460000,860014,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-12-15,45.020000,45.862500,44.500000,45.570000,45.570000,687175,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-12-16,45.120000,46.230000,44.200000,45.630000,45.630000,1110823,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-12-19,45.430000,45.670000,41.560000,41.700000,41.700000,901960,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-12-20,41.130000,44.080000,41.130000,43.900000,43.900000,797043,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-12-21,43.960000,46.050000,43.580000,44.110000,44.110000,605093,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-12-22,43.570000,45.560000,43.570000,44.800000,44.800000,487705,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-12-23,44.550000,44.550000,42.740000,43.520000,43.520000,686796,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-12-27,43.550000,43.725000,42.710000,42.870000,42.870000,505782,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-12-28,42.840000,43.970000,42.460000,43.520000,43.520000,495318,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-12-29,43.890000,46.370000,43.685000,45.170000,45.170000,549353,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
2022-12-30,45.080000,46.510000,44.500000,46.330000,46.330000,553250,0.000000,1.000000,RARE,Common Stock,Ultragenyx,"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.",1515673,NASDAQ,USD,USA,LIFE SCIENCES,PHARMACEUTICAL PREPARATIONS,"60 LEVERONI COURT, NOVATO, CA, US",https://www.ultragenyx.com,December,2025-03-31,3773171000,-477876992,None,-0.24,1.539,None,None,-5.83,6.32,-0.93,-1.026,-0.245,-3.771,590689000,-182318000,-5.83,0,0.28,89.84,6,13,1,0,0,-,-,6.39,26.16,5.62,-6.46,0.242,60.37,29.59,36.75,43.26,94542000,90977000,3.200,98.446,None,None
